UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended: ~~March 31,~~September 30, 2019 or

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________________ to ________________

Commission file number: 0-25426

NATIONAL INSTRUMENTS ~~CORPORATION~~CORPORATION

(Exact name of registrant as specified in its charter)



Delaware		74-1871327
(State or other jurisdiction of incorporation or organization)		~~74-1871327~~ (I.R.S. Employer Identification Number)

11500 North MoPac Expressway ~~Austin, Texas~~
Austin,		78759
Texas
(address of principal executive offices)		(zip code)

Registrant's telephone number, including area code: (512) 683-0100

~~___________________~~Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading symbol(s)	Name of exchange on which registered
Common Stock, $0.01 par value	NATI	Nasdaq Stock Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ~~☒No☐~~ ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. ~~(Check one):~~

~~Large accelerated filer ☒Accelerated filer ☐Non-accelerated filer ☐Smaller reporting company ☐ Emerging growth company~~



Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.



Class	Outstanding at ~~April 25,~~October 29, 2019
Common Stock, - $0.01 par value	~~131,866,173~~131,059,097

NATIONAL INSTRUMENTS CORPORATION

INDEX



PART I. FINANCIAL INFORMATION		Page No.

Item 1	Financial Statements:

	Consolidated Balance Sheets
	~~March 31,~~September 30, 2019 (unaudited) and December 31, 2018	3

	Consolidated Statements of Income
	(unaudited) for the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and 2018	4

	Consolidated Statements of Comprehensive Income
	(unaudited) for the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and 2018	5

	Consolidated Statements of Cash Flows
	(unaudited) for the ~~three month periods~~nine months ended ~~March 31,~~September 30, 2019 and 2018	6

	Consolidated Statements of Stockholder's Equity
	(unaudited) for the three and nine months ended September 30, 2019 and 2018	7

	Notes to Consolidated Financial Statements	89

Item 2	Management's Discussion and Analysis of Financial Condition and Results of Operations	2932

Item 3	Quantitative and Qualitative Disclosures about Market Risk	4045

Item 4	Controls and Procedures	4146


PART II. OTHER INFORMATION

Item 1	Legal Proceedings	4146

Item 1A	Risk Factors	4146

Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	5055

Item 53	~~Other Information~~Defaults Upon Senior Securities	5055

Item 64	~~Exhibits~~Mine Safety Disclosures	5155

Item 5	Other Information	55

Item 6	Exhibits	56

	Signatures and Certifications	5457

PART I - FINANCIAL INFORMATION

ITEM 1. Financial Statements

NATIONAL INSTRUMENTS CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)


	March 31,			December 31,			September 30,			December 31,
	2019			2018			2019			2018
Assets	(unaudited)						(unaudited)
Current assets:
Cash and cash equivalents	$	228,766		$	259,386		$	222,773		$	259,386
Short-term investments	251,297			271,396			209,416			271,396
Accounts receivable, net	215,012			242,955			224,305			242,955
Inventories, net	204,710			194,146			206,727			194,146
Prepaid expenses and other current assets	66,434			54,337			66,313			54,337
Total current assets	966,219			1,022,220			929,534			1,022,220
Property and equipment, net	228,164			245,201			239,140			245,201
Goodwill	262,384			264,530			259,430			264,530
Intangible assets, net	104,066			110,783			91,162			110,783
Operating lease right-of-use assets	70,861			—			63,766			—
Other long-term assets	39,644			28,501			45,289			28,501
Total assets	$	1,671,338		$	1,671,235		$	1,628,321		$	1,671,235
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued liabilities	$	50,576		$	48,388
Accounts payable and accrued expenses							$	56,839		$	48,388
Accrued compensation	35,148			45,821			43,109			45,821
Deferred revenue - current	130,336			127,288			124,386			127,288
Operating lease liabilities - current	16,088			—
Other lease liabilities - current							14,038			—
Other current liabilities	27,807			25,913			22,761			25,913
Other taxes payable	28,001			35,574			31,958			35,574
Total current liabilities	287,956			282,984			293,091			282,984
Deferred income taxes	24,268			25,457			25,949			25,457
Liability for uncertain income tax positions	8,025			9,775
Income taxes payable - non-current	74,546			74,546
Liability for uncertain tax positions							7,631			9,775
Income tax payable - non-current							67,046			74,546
Deferred revenue - non-current	32,393			32,636			31,920			32,636
Operating lease liabilities - non-current	38,154			—			33,112			—
Other long-term liabilities	4,743			7,479			7,411			7,479
Total liabilities	470,085			432,877			466,160			432,877
Commitments and contingencies
Stockholders' equity:
Preferred stock: par value $0.01; 5,000,000 shares authorized; none issued and outstanding	—			—			—			—
Common stock: par value $0.01; 360,000,000 shares authorized; 131,866,173 shares and 132,655,941 shares issued and outstanding, respectively	1,319			1,327
Common stock: par value $0.01; 360,000,000 shares authorized; 131,059,097 shares and 132,655,941 shares issued and outstanding, respectively							1,311			1,327
Additional paid-in capital	910,602			897,544			939,121			897,544
Retained earnings	307,153			356,418			245,465			356,418
Accumulated other comprehensive loss	(17,821		)	(16,931		)	(23,736		)	(16,931		)
Total stockholders’ equity	1,201,253			1,238,358			1,162,161			1,238,358
Total liabilities and stockholders’ equity	$	1,671,338		$	1,671,235		$	1,628,321		$	1,671,235

The accompanying notes are an integral part of the financial statements.

NATIONAL INSTRUMENTS CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share data)

(unaudited)


	Three Months Ended						Three Months Ended						Nine Months Ended
	March 31,						September 30,						September 30,
	2019			2018			2019			2018			2019			2018

Net sales:
Product	$	277,702		$	280,359		$	305,247		$	310,216		$	882,747		$	897,355
Software maintenance	33,372			31,538			35,195			35,911			103,000			101,678
Total net sales	311,074			311,897			340,442			346,127			985,747			999,033

Cost of sales:
Product	74,188			72,317			84,127			87,082			240,056			239,205
Software maintenance	1,887			2,206			1,788			1,933			5,700			6,493
Total cost of sales	76,075			74,523			85,915			89,015			245,756			245,698

Gross profit	234,999			237,374			254,527			257,112			739,991			753,335

Operating expenses:
Sales and marketing	117,551			120,117			113,922			118,220			352,340			365,474
Research and development	66,166			61,843			66,558			66,170			200,981			194,921
General and administrative	27,883			27,277			35,711			26,712			92,639			81,882
Gain on sale of assets							(26,842		)	—			(26,842		)	—
Total operating expenses	211,600			209,237			189,349			211,102			619,118			642,277

Operating income	23,399			28,137			65,178			46,010			120,873			111,058

Other income:
Interest income	2,234			1,015			1,930			1,539			6,187			3,845
Net foreign exchange gain	366			979
Other loss, net	(24		)	(519		)
Net foreign exchange loss							(378		)	(956		)	(1,623		)	(2,082		)
Other gain, net							697			1,782			815			169
Income before income taxes	25,975			29,612			67,427			48,375			126,252			112,990
Provision for income taxes	2,755			5,344			15,783			5,181			22,697			14,474

Net income	$	23,220		$	24,268		$	51,644		$	43,194		$	103,555		$	98,516

Basic earnings per share	$	0.18		0.19			$	0.39		$	0.33		$	0.79		$	0.75

Weighted average shares outstanding - basic	132,252			131,127			131,385			132,357			131,896			131,792

Diluted earnings per share	$	0.17		$	0.18		$	0.39		$	0.32		$	0.78		$	0.74

Weighted average shares outstanding - diluted	133,367			132,624			131,889			133,197			132,890			133,067

Dividends declared per share	$	0.25		$	0.23		$	0.25		$	0.23		$	0.75		$	0.69

The accompanying notes are an integral part of these financial statements.

NATIONAL INSTRUMENTS CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

(unaudited)

Three Months Ended
March 31,
2019 2018

Net income $ 23,220
$ 24,268
Other comprehensive income, before tax and net of reclassification adjustments:

Foreign currency translation adjustment (3,067 ) 5,804
Unrealized gain (loss) on securities available-for-sale 1,175
(696 )
Unrealized gain (loss) on derivative instruments 1,212
(3,771 )
Other comprehensive (loss) gain, before tax (680 ) 1,337
Tax benefit (expense) related to items of other comprehensive income 210
(872 )
Other comprehensive (loss) gain, net of tax (890 ) 2,209
Comprehensive income $ 22,330
$ 26,477



	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2019			2018			2019			2018

Net income	$	51,644		$	43,194		$	103,555		$	98,516
Other comprehensive income (loss), before tax and net of reclassification adjustments:
Foreign currency translation adjustment	(8,500		)	(1,359		)	(9,303		)	(7,360		)
Unrealized (loss) gain on securities available-for-sale	(419		)	154			1,494			(404		)
Unrealized gain on derivative instruments	1,627			3,316			1,359			11,578
Other comprehensive (loss) income, before tax	(7,292		)	2,111			(6,450		)	3,814
Tax expense related to items of other comprehensive income	414			720			355			2,479
Other comprehensive (loss) income, net of tax	(7,706		)	1,391			(6,805		)	1,335
Comprehensive income	$	43,938		$	44,585		$	96,750		$	99,851

The accompanying notes are an integral part of these financial statements.

NATIONAL INSTRUMENTS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)


	Three Months Ended						Nine Months Ended
	March 31,						September 30,
	2019			2018			2019			2018
Cash flow from operating activities:
Net income	$	23,220		$	24,268		$	103,555		$	98,516
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,012			17,436			54,546			53,735
Stock-based compensation	11,034			8,204			38,054			27,492
Tax expense from deferred income taxes	(1,650		)	(2,046		)
Disposal gain on sale of assets							(26,842		)	—
Deferred income taxes							(1,461		)	732
Changes in operating assets and liabilities	(8,469		)	(7,879		)	(18,507		)	6,862
Net cash provided by operating activities	42,147			39,983			149,345			187,337

Cash flow from investing activities:
Capital expenditures	(10,936		)	(8,115		)	(47,183		)	(27,373		)
Proceeds from sale of assets							32,492			—
Capitalization of internally developed software	(2,279		)	(7,668		)	(7,179		)	(13,152		)
Additions to other intangibles	(106		)	(2,855		)	(1,132		)	(5,165		)
Payments to acquire equity-method investment	(9,784		)	—
Acquisitions of equity-method investments							(13,670		)	—
Purchases of short-term investments	(60,094		)	(52,355		)	(141,074		)	(172,462		)
Sales and maturities of short-term investments	81,151			10,211			204,046			122,726
Net cash used in investing activities	(2,048		)	(60,782		)
Net cash provided by (used in) investing activities							26,300			(95,426		)

Cash flow from financing activities:
Proceeds from issuance of common stock	9,213			8,600			25,823			24,424
Repurchase of common stock	(46,404		)	—			(137,171		)	—
Dividends paid	(33,110		)	(30,177		)	(99,083		)	(91,034		)
Net cash used in financing activities	(70,301		)	(21,577		)	(210,431		)	(66,610		)

Effect of exchange rate changes on cash	(418		)	2,577			(1,827		)	(4,084		)

Net change in cash and cash equivalents	(30,620		)	(39,799		)	(36,613		)	21,217
Cash and cash equivalents at beginning of period	259,386			290,164			259,386			290,164
Cash and cash equivalents at end of period	$	228,766		$	250,365		$	222,773		$	311,381

The accompanying notes are an integral part of these financial statements.

NATIONAL INSTRUMENTS CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share data)

(unaudited)

March 31, 2019
Common Stock Shares Common Stock Amount Additional-Paid in Capital Retained Earnings Accumulated Other Comprehensive Income/(Loss) Total Stockholders' Equity
Balance at December 31, 2018 132,655,941
$ 1,327
$ 897,544
$ 356,418
$ (16,931 ) $ 1,238,358
Net income —
—
—
23,220
—
23,220
Other comprehensive loss, net of tax —
—
—
—
(890 ) (890 )
Issuance of common stock under employee plans, including tax benefits 245,330
2
9,211
—
—
9,213
Stock-based compensation —
—
10,866
—
—
10,866
Repurchase of common stock (1,035,098 ) (10 ) (7,019 ) (39,375 ) —
(46,404 )
Dividends paid (1) —
—
—
(33,110 ) —
(33,110 )
Balance at March 31, 2019 131,866,173
$ 1,319
$ 910,602
$ 307,153
$ (17,821 ) $ 1,201,253

March 31, 2018
Common Stock Shares Common Stock Amount Additional-Paid in Capital Retained Earnings Accumulated Other Comprehensive Income/(Loss) Total Stockholders' Equity
Balance at December 31, 2017 $ 130,978,947
$ 1,310
$ 829,979
$ 313,241
$ (16,509 ) $ 1,128,021
Net income —
—
—
24,268
—
24,268
Other comprehensive income, net of tax —
—
—
—
2,209
2,209
Issuance of common stock under employee plans, including tax benefits 225,848
2
8,598
—
—
8,600
Stock-based compensation —
—
8,166
—
—
8,166
Adoption of ASU 2014-09 —
—
—
8,619
—
8,619
Dividends paid (1) —
—
—
(30,177 ) —
(30,177 )
Balance at March 31, 2018 131,204,795
1,312
846,743
315,951
(14,300 ) 1,149,706



	Common Stock Shares		Common Stock Amount			Additional-Paid in Capital			Retained Earnings			Accumulated Other Comprehensive Income/(Loss)			Total Stockholders' Equity
Balance at June 30, 2019	131,884,775		$	1,319		$	924,801		$	264,484		$	(16,030	)	$	1,174,574
Net income	—		—			—			51,644			—			51,644
Other comprehensive loss, net of tax	—		—			—			—			(7,706		)	(7,706		)
Issuance of common stock under employee plans	230,400		3			8,175			—			—			8,178
Stock-based compensation	—		—			13,284			—			—			13,284
Repurchase of common stock	(1,056,078	)	(11		)	(7,139		)	(37,647		)	—			(44,797		)
Dividends paid (1)	—		—			—			(33,016		)	—			(33,016		)
Balance at September 30, 2019	131,059,097		1,311			939,121			245,465			(23,736		)	1,162,161

	Common Stock Shares		Common Stock Amount			Additional-Paid in Capital			Retained Earnings			Accumulated Other Comprehensive Income/(Loss)			Total Stockholders' Equity
Balance at December 31, 2018	132,655,941		1,327			897,544			356,418			(16,931		)	1,238,358
Net income	—		—			—			103,555			—			103,555
Other comprehensive loss, net of tax	—		—			—			—			(6,805		)	(6,805		)
Issuance of common stock under employee plans	1,608,832		16			25,807			—			—			25,823
Stock-based compensation	—		—			37,484			—			—			37,484
Repurchase of common stock	(3,205,676	)	(32		)	(21,714		)	(115,425		)	—			(137,171		)
Dividends paid (1)	—		—			—			(99,083		)	—			(99,083		)
Balance at September 30, 2019	131,059,097		$	1,311		$	939,121		$	245,465		$	(23,736	)	$	1,162,161

(1) Cash dividends declared per share of common stock were $0.25 for the three months ended September 30, 2019, and $0.75 for the nine months ended September 30, 2019.

The accompanying notes are an integral part of these financial statements.



	Common Stock Shares	Common Stock Amount		Additional-Paid in Capital		Retained Earnings			Accumulated Other Comprehensive Income/(Loss)			Total Stockholders' Equity
Balance at June 30, 2018	132,208,105	$	1,322	$	864,314	$	316,607		$	(16,565	)	$	1,165,678
Net income	—	—		—		43,194			—			43,194
Other comprehensive income, net of tax	—	—		—		—			1,391			1,391
Issuance of common stock under employee plans	224,489	2		7,800		—			—			7,802
Stock-based compensation	—	—		9,303		—			—			9,303
Dividends paid (1)	—	—		—		(30,459		)	—			(30,459		)
Balance at September 30, 2018	132,432,594	1,324		881,417		329,342			(15,174		)	1,196,909

	Common Stock Shares	Common Stock Amount		Additional-Paid in Capital		Retained Earnings			Accumulated Other Comprehensive Income/(Loss)			Total Stockholders' Equity
Balance at December 31, 2017	130,978,947	1,310		829,979		313,241			(16,509		)	1,128,021
Net income	—	—		—		98,516			—			98,516
Other comprehensive income, net of tax	—	—		—		—			1,335			1,335
Issuance of common stock under employee plans	1,453,647	14		24,409		—			—			24,423
Stock-based compensation	—	—		27,029		—			—			27,029
Adoption of ASU 2014-09	—	—		—		8,619			—			8,619
Dividends paid (1)	—	—		—		(91,034		)	—			(91,034		)
Balance at September 30, 2018	132,432,594	$	1,324	$	881,417	$	329,342		$	(15,174	)	$	1,196,909

(1) Cash dividends declared per share of common stock were $0.23 for the three ~~month periods~~months ended ~~March 31, 2019 and~~September 30, 2018, ~~respectively.~~$0.69 for the nine months ended September 30, 2018.

The accompanying notes are an integral part of these financial statements.

NATIONAL INSTRUMENTS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Basis of presentation

The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2018, included in our annual report on Form 10-K, filed with the Securities and Exchange ~~Commission.~~Commission ("SEC"). In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to present fairly our financial position at ~~March 31,~~September 30, 2019 and December 31, 2018, the results of our operations and comprehensive income for ~~the~~ three and nine months ended ~~March 31,~~September 30, 2019 and 2018, the cash flows for the nine months ended September 30, 2019 and 2018 and the ~~cash flows~~statement of stockholder's equity for the three and nine months ended ~~March 31, 2019 and 2018.~~September 30, 2019. Our operating results for the three and nine months ended ~~March 31,~~September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States.

Gain on Sale of Assets

During the three months ended September 30, 2019, we recognized a gain of $26.8 million from the sale of our 136,000 square foot office building and property located at 6504 Bridgepoint Parkway, Austin, Texas (the "Millennium Property"). At the time of sale, we did not occupy the building and had been leasing the building to third parties for several years. The disposal gain is presented as "Gain on sale of assets" in the Consolidated Statements of Income.

Recently Adopted Accounting Pronouncements

Leases

In February 2016, the Financial Accounting Standards Board ("FASB") established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which supersedes ASC 840, Leases, and requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. Topic 842, as amended (the "new lease standard"), establishes a right-of-use ("ROU") model ~~(ROU)~~ that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.

We adopted the new lease standard on January 1, 2019 and used the effective date as our date of initial adoption. Consequently, financial information will not be updated and the disclosures required under the new lease standard will not be provided for earlier periods.

We have completed a qualitative and quantitative assessment of our lease portfolio, in which the new lease standard had a material impact on our consolidated balance sheet but did not have an impact on our consolidated income statement. Upon adoption, we recognized lease liabilities of approximately $52 million, with corresponding ROU assets of the same amount, based on the present value of the remaining minimum rental payments under current leasing standards for our existing operating leases. Additionally, we also reclassified approximately $19 million from "Property, plant and equipment, net" to "Operating lease right-of-use assets" related to prepaid leasehold land.

The new lease standard provides a number of optional practical expedients in transition. We elected the ~~'package~~"package of practical ~~expedients'~~expedients", which permits us not to reassess under the new lease standard our prior conclusions about lease identification, lease classification and initial direct costs. ~~We did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.~~ The new lease standard also provides practical expedients for an entity's ongoing accounting. We elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. We also elected the practical expedient to not separate lease and non-lease components for our office leases.

The cumulative effects of the changes made to our consolidated January 1, 2019 balance sheet for the adoption of the new lease standard were as follows (in thousands):



	Balance at December 31, 2018		Adjustments Due to ASU 2016-02			Balance at January 1, 2019

Assets
Property, plant and equipment, net	$	245,201	$	(18,606	)	$	226,595
Operating lease right-of-use assets	—		$	68,938		$	68,938

Liabilities and Stockholders' Equity
Operating lease liabilities, current	—		$	18,597		$	18,597
Operating lease liabilities, non-current	—		$	33,853		$	33,853
Other current liabilities	$	25,913	$	(2,118	)	$	23,795

Balance at December 31, 2018 Adjustments Due to ASU 2016-02 Balance at January 1, 2019

Assets
Property, plant and equipment, net $ 245,201
$ (18,606 ) $ 226,595
Operating lease right-of-use assets —
68,938
68,938

Liabilities and Stockholders' Equity
Operating lease liabilities, current —
18,597
18,597
Operating lease liabilities, non-current —
$ 33,853
$ 33,853
Other current liabilities $ 25,913
$ (2,118 ) $ 23,795

Other Recently Adopted Accounting Pronouncements

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The ASU expands strategies that qualify for hedge accounting, changes how many hedging relationships are presented in the financial statements, and simplifies the application of hedge accounting in certain situations. On January 1, 2019, we adopted the guidance in ASU 2017-12. Adoption did not have a material impact on our financial statements. We continue to assess opportunities enabled by the new standard to expand our risk management strategies.

In August 2018, the ~~Securities and Exchange Commission ("SEC")~~SEC issued Release No. 33-10532 that amends and clarifies certain financial reporting requirements. The principal change to our financial reporting will be the inclusion of the annual disclosure requirement of changes in stockholders’ equity in Rule 3-04 of Regulation S-X to interim periods. We adopted this new rule beginning with our financial reporting for the quarter ended March 31, 2019.

In January 2018, the FASB issued ASU 2018-02, Income Statement — Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which gives entities the option to reclassify to retained earnings tax effects resulting from the Tax Cuts and Jobs Act (the "Act") related to items that the FASB refers to as having been stranded in accumulated other comprehensive income ("OCI"). We adopted ASU 2018-02 effective January 1, 2019, and we did not elect the option to reclassify to retained earnings the tax effects resulting from the Act that are stranded in accumulated OCI. The adoption of the new guidance did not have a material effect on our consolidated financial statements.

Recent Accounting Guidance Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU will replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. We will be required to use a forward-looking expected credit loss model for accounts receivables and other financial instruments. This ASU requires instruments measured at amortized cost to be presented at the net amount expected to be collected. Entities are also required to record allowances for available-for-sale debt securities rather than reduce the carrying amount. We do not plan to adopt the ASU earlier than our required effective date of January 1, 2020. We expect that the adoption of the ASU will not have a material impact on our financial statements.

Summary of Significant Accounting Policies

As discussed above, we adopted the new lease standard as of January 1, 2019. The impact of this new guidance on our accounting policies and financial statements is described below. Additionally, in the first quarter of 2019, we granted performance-based restricted stock units to certain executives under our 2015 Equity Incentive Plan ("PRSUs"). The PRSU awards granted during the ~~three~~nine months ended ~~March 31,~~September 30, 2019 include a market condition as defined by ASC 718. The impact of the new equity awards on our accounting policies is described below. There were no other significant changes in our accounting policies during the ~~three~~nine months ended ~~March 31,~~September 30, 2019 compared to the significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2018.

Stock-Based Compensation

Stock-based compensation costs are based on the fair value on the date of grant for all restricted stock units ("RSUs") and on the date of enrollment for the employee stock purchase plan. We recognize compensation expense ratably over the requisite service period of the awards. PRSUs are ~~restricted stock unit~~RSU awards that vest based on a market condition. The market condition currently used is our stockholder return relative to the total stockholder return of the ~~constituents of~~companies included in the Russell 2000 Index at the end of athe three-year performance period. Up to 200% of the full target number of shares subject to each PRSU award are eligible to be earned after the completion of the three-year performance period based on our total stockholder return relative to the total stockholder return of the Russell 2000 ~~Index at the end of the performance period.~~Index.

The fair values of RSUs, with service-based vesting conditions, are estimated using their market price on the date of grant. The fair values of rights under employee stock purchase plans are estimated using the Black-Scholes option-pricing model. The fair values of PRSUs are estimated using a Monte Carlo simulation. The determination of fair value of the PRSUs is affected by our stock price and a number of assumptions including the expected volatility, expected dividend yield and the risk-free interest rate. Our expected volatility at the date of grant was based on the historical volatilities of our stock and the ~~constituents of~~companies included in the Russell 2000 Index over the performance period.

Refer to Note 11 – Authorized shares of common and preferred stock and stock-based compensation plans for additional information on our equity-based compensation programs.

Leases

We determine whether an arrangement is a lease at inception. Operating leases are included in operating lease ~~right-of-use ("ROU")~~ROU assets and operating lease liabilities (current and non-current) on our consolidated balance sheet. Finance leases are included in property and equipment, other current liabilities, and other long-term liabilities in our consolidated balance sheet.

Operating lease ROU assets and operating lease liabilities are recognized based on their present value of the future minimum lease payments over the lease term at commencement date. As none of our leases provide an implicit rate we use our incremental borrowing rate based on the information available as of the commencement date. The operating lease ROU assets also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

We have lease agreements with lease and non-lease components. For office leases, we account for the lease and non-lease components as a single lease component. For certain leases, such as equipment and vehicles, we account for the lease and non-lease components separately. Additionally, for certain equipment leases, we apply a portfolio approach to effectively account for the operating lease ROU assets and liabilities. Refer to Note 8 - Leases for additional information on our leasing activities.

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes RSUs, is computed using the treasury stock method.

The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three and nine months ended ~~March 31,~~September 30, 2019 and 2018, are as follows:



	Three Months Ended September 30,		Nine Months Ended September 30,
	(In thousands)		(In thousands)
	(Unaudited)		(Unaudited)
	2019	2018	2019	2018
Weighted average shares outstanding-basic	131,385	132,357	131,896	131,792
Plus: Common share equivalents
RSUs	504	840	994	1,275
Weighted average shares outstanding-diluted	131,889	133,197	132,890	133,067

Three Months Ended March 31,
(In thousands)
(Unaudited)
2019 2018
Weighted average shares outstanding-basic 132,252
131,127
Plus: Common share equivalents

RSUs 1,115
1,497
Weighted average shares outstanding-diluted 133,367
132,624

Stock awards to acquire ~~67,100~~1,611,000 shares and 036,600 shares for the three months ended ~~March 31,~~September 30, 2019 and 2018, respectively, and 568,000 shares and 537,000 shares for the nine months ended September 30, 2019 and 2018, respectively, were excluded in the computations of diluted EPS because the effect of including the stock awards would have been anti-dilutive.

Note 2 - Revenue

Revenue Recognition

Revenue is recognized upon transfer of control of the promised products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. We enter into contracts that can include various combinations of our products or services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Our typical performance obligations include the following:



Performance Obligation	When performance obligation is typically satisfied	When payment is typically due	How standalone selling price is typically estimated
Product revenue
Modular hardware	When customer obtains control of the product (point-in-time)	Within 30-90 days of shipment	Observable in transactions without multiple performance obligations
Software licenses	When software media is delivered to customer or made available for download electronically, and the applicable license period has begun (point-in-time)	Within 30-90 days of the beginning of license period	Perpetual/Subscription licenses: Value relationships based on (i) the directly observable pricing of the license bundled with software maintenance and (ii) the directly observable pricing of software maintenance renewals, when they are sold on a standalone basis. Enterprise-wide term licenses: Residual method
Extended hardware warranty	Ratably over the course of the support contract (over time)	Within 30-90 days of the beginning of the contract period	Observable in renewal transactions
Other related support offerings	As work is performed (over time) or training course is delivered (point-in-time)	Within 30-90 days of delivery	Observable in transactions without multiple performance obligations
Software maintenance revenue
Software maintenance	Ratably over the course of the support contract (over time)	Within 30-90 days of the beginning of the contract period	Observable in renewal transactions

Disaggregation of Revenues

We disaggregate revenue from contracts with customers based on the timing of transfer of goods or services to customers (point-in-time or over time) and geographic region based on the billing location of the customer. The geographic regions that are tracked are the Americas (United States, Canada and Latin America), EMEIA (Europe, Middle East, India and Africa) and APAC (Australia, New Zealand, Southeast Asia, China, South Korea and Japan). ~~We operate as one operating segment.~~

Total net sales based on the disaggregation criteria described above are as follows:

Three Months Ended March 31,
(In thousands) (Unaudited)
2019 2018

Net sales:
Point-in-Time⁽¹⁾
Over Time Total
Point-in-Time⁽¹⁾
Over Time Total
Americas $ 99,681
22,974
$ 122,655
$ 100,053
19,669
$ 119,722
EMEIA 79,122
19,685
98,807
86,907
18,505
105,412
APAC 81,450
8,162
89,612
78,685
8,078
86,763
Total net sales⁽¹⁾
$ 260,253
50,821
$ 311,074
$ 265,645
46,252
$ 311,897
(1): Net sales contains hedging gains and losses, which do not represent revenues recognized from customers.
See Note - 5 Derivatives instruments and hedging activities for more information on the impact of our hedging activities on our results of operations



			Three Months Ended September 30,
(In thousands)			(Unaudited)
	2019						2018

Net sales:	Point-in-Time		Over Time		Total		Point-in-Time		Over Time		Total
Americas	$	119,895	$	23,222	$	143,117	$	118,725	$	24,191	$	142,916
EMEIA	75,443		20,247		95,690		79,952		19,461		99,413
APAC	92,794		8,841		101,635		95,837		7,961		103,798
Total net sales⁽¹⁾	$	288,132	$	52,310	$	340,442	$	294,514	$	51,613	$	346,127
(1) Net sales contains hedging gains and losses, which do not represent revenues recognized from customers. See Note - 5 Derivatives instruments and hedging activities for more information on the impact of our hedging activities on our results of operations



			Nine Months Ended September 30,
(In thousands)			(Unaudited)
	2019						2018

Net sales:	Point-in-Time		Over Time		Total		Point-in-Time		Over Time		Total
Americas	$	325,349	$	69,337	$	394,686	$	327,958	$	64,471	$	392,429
EMEIA	234,409		59,121		293,530		257,346		57,520		314,866
APAC	272,375		25,156		297,531		267,773		23,965		291,738
Total net sales⁽¹⁾	$	832,133	$	153,614	$	985,747	$	853,077	$	145,956	$	999,033
(1) Net sales contains hedging gains and losses, which do not represent revenues recognized from customers. See Note - 5 Derivatives instruments and hedging activities for more information on the impact of our hedging activities on our results of operations

Information about Contract Balances

Amounts collected in advance of services being provided are accounted for as deferred revenue. Nearly all of our deferred revenue balance is related to extended hardware and software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 90 days of contract inception. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our products and services, not to receive financing from our customers, such as invoicing at the beginning of a subscription term with a portion of the revenue recognized ratably over the contract period, or to provide customers with financing, such as multi-year on-premises licenses that are invoiced annually with revenue recognized upfront.

Changes in deferred revenue, current and ~~non-current,~~long-term, during the ~~three~~nine months ended ~~March 31,~~September 30, 2019 were as follows:


	Amount			Amount
	(In thousands)			(In thousands)
Deferred Revenue at December 31, 2018	$	159,924		$	159,924
Deferral of revenue billed in current period, net of recognition	51,562			149,961
Recognition of revenue deferred in prior periods	(47,995		)	(150,762		)
Foreign currency translation impact	(762		)	(2,817		)
Balance as of March 31, 2019 (unaudited)	$	162,729
Balance as of September 30, 2019 (unaudited)				$	156,306

For the ~~three~~nine months ended ~~March 31,~~September 30, 2019, revenue recognized from performance obligations ~~related to~~satisfied in prior periods (for example, due to changes in transaction price) was not material. Amounts recognized as revenue in excess of amounts billed are recorded as unbilled receivables. Unbilled receivables which are anticipated to be invoiced in the next twelve months are included in "accounts receivable, net" on the consolidated balance sheet. Based on the nature of our contracts with customers, we do not typically recognize unbilled receivables related to revenues recognized in excess of amounts billed. For the ~~three~~nine months ended ~~March 31,~~September 30, 2019, amounts recognized related to unbilled receivables were not material.

Unsatisfied Performance Obligations

Revenue expected to be recognized in any future period related to remaining performance obligations, excluding revenue pertaining to contracts that have an original expected duration of one year or less, and excluding contracts where revenue is recognized as invoiced, was approximately $57 million as of ~~March 31,~~September 30, 2019. Since we typically invoice customers at contract inception, this amount is included in our current and non-current deferred revenue balances. As of ~~March 31,~~September 30, 2019, we expect to recognize approximately ~~37%~~13% of the revenue related to these unsatisfied performance obligations during the remainder of 2019, ~~35%~~45% during 2020, and ~~28%~~42% thereafter.

Assets Recognized from the Costs to Obtain a Contract with a Customer

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. Capitalized incremental costs related to initial contracts and renewals are amortized over the same period because the commissions paid on both the initial contract and renewals are commensurate with one another. Total capitalized costs to obtain a contract were immaterial during the periods presented and are included in other long-term assets on our consolidated balance sheets.

Practical Expedients

As discussed in Note 1 - Basis of presentation and elsewhere in Note 2 - Revenue, we have elected the following practical expedients in accordance with the new revenue standard:

We generally expense sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within sales and marketing expenses.

We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

We do not consider the time value of money for contracts with original durations of one year or less.

Note 3 –Short-term investments

The following tables summarize unrealized gains and losses related to our short-term investments designated as ~~available-for-sale debt securities:~~available-for-sale:



	As of September 30, 2019
(In thousands)	(Unaudited)
			Gross		Gross
	Adjusted Cost		Unrealized Gain		Unrealized Loss			Fair Value
Corporate bonds	$	208,480	$	1,072	$	(159	)	$	209,393
Time deposits	23		—		—			23
Total Short-term investments	$	208,503	$	1,072	$	(159	)	$	209,416



(In thousands)	As of December 31, 2018
			Gross		Gross
	Adjusted Cost		Unrealized Gain		Unrealized Loss			Fair Value
Corporate bonds	$	235,045	$	726	$	(1,298	)	$	234,473
U.S. treasuries and agencies	36,932		2		(11		)	36,923
Total Short-term investments	$	271,977	$	728	$	(1,309	)	$	271,396

As of March 31, 2019
(In thousands) (Unaudited)
Gross Gross
Adjusted Cost Unrealized Gain Unrealized Loss Fair Value
Corporate bonds $ 203,851
$ 915
$ (347 ) $ 204,419
U.S. treasuries and agencies 46,852
27
(1 ) 46,878
Total Short-term investments $ 250,703
$ 942
$ (348 ) $ 251,297

(In thousands) As of December 31, 2018
Gross Gross
Adjusted Cost Unrealized Gain Unrealized Loss Fair Value
Corporate bonds $ 235,045
$ 726
$ (1,298 ) $ 234,473
U.S. treasuries and agencies 36,932
2
(11 ) 36,923
Total Short-term investments $ 271,977
$ 728
$ (1,309 ) $ 271,396

The following tables summarize the contractual maturities of our short-term investments designated as ~~available-for-sale debt securities:~~

available-for-sale:



	As of September 30, 2019
(In thousands)	(Unaudited)
	Adjusted Cost		Fair Value
Due in less than 1 year	$	69,120	$	69,406
Due in 1 to 5 years	139,383		140,010
Total available-for-sale debt securities	$	208,503	$	209,416

Due in less than 1 year	Adjusted Cost		Fair Value
Corporate bonds	$	69,097	$	69,383
Time deposits	23		23
Total available-for-sale debt securities	$	69,120	$	69,406

Due in 1 to 5 years	Adjusted Cost		Fair Value
Corporate bonds	$	139,383	$	140,010
Total available-for-sale debt securities	$	139,383	$	140,010

As of March 31, 2019
(In thousands) (Unaudited)
Adjusted Cost Fair Value
Due in less than 1 year $ 132,980
$ 133,008
Due in 1 to 5 years 117,723
118,289
Total available-for-sale debt securities $ 250,703
$ 251,297

Due in less than 1 year Adjusted Cost Fair Value
Corporate bonds $ 86,128
$ 86,130
U.S. treasuries and agencies 46,852
46,878
Total available-for-sale debt securities $ 132,980
$ 133,008

Due in 1 to 5 years Adjusted Cost Fair Value
Corporate bonds $ 117,723
$ 118,289
Total available-for-sale debt securities $ 117,723
$ 118,289

Equity-Method Investments

The carrying value of our equity method investments was ~~$13~~$16 million as of ~~March 31,~~September 30, 2019. Our proportionate share of the income from equity-method investments was not material for the periods presented.

Note 4 – Fair value measurements

We define fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market that market participants may use when pricing the asset or liability.

We follow a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value measurement is determined based on the lowest level input that is significant to the fair value measurement. The three values of the fair value hierarchy are the following:

Level 1 – Quoted prices in active markets for identical assets or liabilities

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

Level 3 – Inputs that are not based on observable market data

Assets and liabilities measured at fair value on a recurring basis are summarized below:


	Fair Value Measurements at Reporting Date Using										Fair Value Measurements at Reporting Date Using
(In thousands)	(Unaudited)										(Unaudited)
Description	March 31, 2019			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)		September 30, 2019			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets
Cash and cash equivalents available for sale:
Money Market Funds	$	57,584		$	57,584	$	—		$	—	$	106,327		$	106,327	$	—		$	—
Short-term investments available for sale:
Corporate bonds	204,419			—		204,419			—
U.S. treasuries and agencies	46,878			—		46,878			—
Corporate notes and bonds											209,393			—		209,393			—
Time deposits											23			23		—			—
Derivatives	10,753			—		10,753					15,597			—		15,597			—
Total Assets	$	319,634		$	57,584	$	262,050		$	—	$	331,340		$	106,350	$	224,990		$	—

Liabilities
Derivatives	$	(1,461	)	$	—	$	(1,461	)	$	—	$	(6,282	)	$	—	$	(6,282	)	$	—
Total Liabilities	$	(1,461	)	$	—	$	(1,461	)	$	—	$	(6,282	)	$	—	$	(6,282	)	$	—



(In thousands)	Fair Value Measurements at Reporting Date Using
Description	December 31, 2018			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets
Cash and cash equivalents available for sale:
Money Market Funds	$	62,094		$	62,094	$	—		$	—
Corporate notes and bonds	9,979			—		9,979			—
Short-term investments available for sale:
Corporate bonds	234,473			—		234,473			—
U.S. treasuries and agencies	36,923			—		36,923			—
Derivatives	9,369			—		9,369			—
Total Assets	$	352,838		$	62,094	$	290,744		$	—

Liabilities
Derivatives	$	(1,483	)	$	—	$	(1,483	)	$	—
Total Liabilities	$	(1,483	)	$	—	$	(1,483	)	$	—

(In thousands) Fair Value Measurements at Reporting Date Using
Description December 31, 2018 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3)
Assets
Cash and cash equivalents available for sale:
Money Market Funds $ 62,094
$ 62,094
$ —
$ —
Corporate notes and bonds 9,979
—
9,979
—
Short-term investments available for sale:
Corporate bonds 234,473
—
234,473
—
Time deposits 36,923
—
36,923
—
Derivatives 9,369
—
9,369
—
Total Assets
$ 352,838
$ 62,094
$ 290,744
$ —

Liabilities
Derivatives $ (1,483 ) $ —
$ (1,483 ) $ —
Total Liabilities
$ (1,483 ) $ —
$ (1,483 ) $ —

We value our available-for-sale short-term investments based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe all of these sources reflect the credit risk associated with each of our available-for-sale short-term investments. Short-term investments available-for-sale consists of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government organizations and agencies. All of our short-term investments available-for-sale have contractual maturities of less than 60 months.

~~Our derivatives consist of~~

Derivatives include foreign currency forward contracts. Our foreign currency forward contracts are valued using an income approach (Level 2) based on the spot rate less the contract rate multiplied by the notional amount. We consider counterparty credit risk in the valuation of our derivatives. However, counterparty credit risk did not impact the valuation of our derivatives during the ~~three~~nine months ended ~~March 31,~~September 30, 2019. There were no transfers in or out of Level 1 or Level 2 during the ~~three~~nine months ended ~~March 31,~~September 30, 2019.

As of ~~March 31,~~September 30, 2019, our short-term investments did not include sovereign debt from any country other than the United States.

We did not have any items that were measured at fair value on a nonrecurring basis at ~~March 31,~~September 30, 2019 and December 31, 2018. The carrying value of net accounts receivable, accounts payable, and long-term debt contained in the consolidated balance sheets approximates fair value.

Note 5 – Derivative instruments and hedging activities

We recognize all of our derivative instruments as either assets or liabilities in our statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

We have operations in ~~over~~approximately 50 countries. Sales outside of the Americas accounted for approximately ~~61%~~58% and ~~62%~~59% of our net sales during the three months ended ~~March 31,~~September 30, 2019 and 2018, respectively, and approximately 60% and 61% of our net sales during the nine months ended September 30, 2019 and 2018, respectively. Our activities expose us to a variety of market risks, including the effects of changes in foreign currency exchange rates. These financial risks are monitored and managed by us as an integral part of our overall risk management program.

We maintain a foreign currency risk management strategy that uses derivative instruments (foreign currency forward contracts) to help protect our earnings and cash flows from fluctuations caused by the volatility in currency exchange rates. Movements in foreign currency exchange rates pose a risk to our operations and competitive position, in that exchange rate changes may affect our profitability and cash flow, and the business or pricing strategies of our non-U.S. based competitors.

The vast majority of our foreign sales are denominated in the customers’ local currency. We purchase foreign currency forward contracts as hedges of forecasted sales that are denominated in foreign currencies and as hedges of foreign currency denominated financial assets or liabilities. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash inflows resulting from such sales or firm commitments will be adversely affected by changes in exchange rates. We also purchase foreign currency forward contracts as hedges of forecasted expenses that are denominated in foreign currencies. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash outflows resulting from foreign currency operating and cost of sales expenses will be adversely affected by changes in exchange rates.

We designate foreign currency forward contracts as cash flow hedges of forecasted net sales or forecasted expenses. In addition, we hedge our foreign currency denominated balance sheet exposures using foreign currency forward contracts that are not designated as hedging instruments. None of our derivative instruments contain a credit-risk-related contingent feature.

Cash flow hedges

To help protect against the reduction in value caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales over the next one to three years, we have instituted a foreign currency cash flow hedging program. We hedge portions of our forecasted net sales and forecasted expenses denominated in foreign currencies with forward contracts. For forward contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the forward contracts designated as hedges. We purchase foreign currency forward contracts for up to 100% of our forecasted exposures in selected currencies (primarily in Euro, Japanese yen, Hungarian forint, British pound, Malaysian ringgit, Korean won and Chinese ~~yuan, and Korean won)~~yuan) and limit the duration of these contracts to 3640 months or less.

For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of accumulated OCI and reclassified into earnings in the same line item (net sales, operating expenses, or cost of sales) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings or expenses during the current period and are classified as a component of “net foreign exchange loss.” Hedge effectiveness of foreign currency forwards designated as cash flow hedges are measured by comparing the hedging instrument’s cumulative change in fair value from inception to maturity to the forecasted transaction’s terminal value.

We held forward contracts designated as cash flow hedges with the following notional amounts:



(In thousands)	US Dollar Equivalent
	As of September 30, 2019		As of December 31,
	(Unaudited)		2018
British pound	$	17,748	$	9,948
Chinese yuan	52,937		45,520
Euro	158,214		134,654
Hungarian forint	102,732		35,384
Japanese yen	54,094		15,141
Korean won	9,401		8,331
Malaysian ringgit	28,258		27,778
Total forward contracts notional amount	$	423,384	$	276,756

(In thousands) US Dollar Equivalent
As of March 31, 2019 As of December 31,
(Unaudited) 2018
Chinese yuan 79,931
$ 45,520
Euro 141,484
134,654
Japanese yen 22,543
15,141
Hungarian forint 32,192
35,384
British pound 8,892
9,948
Malaysian ringgit 25,245
27,778
Korean won 13,608
8,331
Total forward contracts notional amount $ 323,895
$ 276,756

The contracts in the foregoing table had contractual maturities of 2139 months or less and 24 months or less at ~~March 31,~~September 30, 2019 and December 31, 2018, respectively.

At ~~March 31,~~September 30, 2019, we expect to reclassify ~~$7.3~~$11.6 million of gains on derivative instruments from accumulated OCI to net sales during the next twelve months when the hedged international sales occur, ~~$(0.1)~~$1.9 million of losses on derivative instruments from accumulated OCI to cost of sales during the next twelve months when the hedged cost of sales are incurred and ~~$(0.1)~~$1.3 million of losses on derivative instruments from accumulated OCI to operating expenses during the next twelve months when the hedged operating expenses occur. Expected amounts are based on derivative valuations at ~~March 31,~~September 30, 2019. Actual results may vary materially as a result of changes in the corresponding exchange rates subsequent to this date.

The gains and losses recognized in earnings due to hedge ineffectiveness were not material for each of the nine months ended September 30, 2019 and 2018 and are included as a component of net income under the line item “net foreign exchange loss.”

Other Derivatives

Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge our foreign denominated net receivable or net payable positions to help protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically attempt to hedge up to 90% of our outstanding foreign denominated net receivables or net payables and typically limit the duration of these foreign currency forward contracts to approximately 90 days or less. The gain or loss on the derivatives as well as the offsetting gain or loss on the hedge item attributable to the hedged risk is recognized in current earnings under the line item “net foreign exchange ~~gain (loss).~~loss.” As of ~~March 31,~~September 30, 2019 and December 31, 2018, we held foreign currency forward contracts that were not designated as hedging instruments with a notional amount of ~~$42~~$47 million and $71 million, respectively.

The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets at ~~March 31,~~September 30, 2019 and December 31, 2018, respectively.

Asset Derivatives
March 31, 2019 December 31, 2018
(In thousands) (Unaudited)

Balance Sheet Location Fair Value Balance Sheet Location Fair Value
Derivatives designated as hedging instruments

Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 7,811
Prepaid expenses and other current assets $ 7,594

Foreign exchange contracts - LT forwards Other long-term assets 2,487
Other long-term assets 1,380
Total derivatives designated as hedging instruments $ 10,298
$ 8,974

Derivatives not designated as hedging instruments

Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 455
Prepaid expenses and other current assets $ 395
Total derivatives not designated as hedging instruments $ 455
$ 395

Total derivatives $ 10,753
$ 9,369


	Liability Derivatives								Asset Derivatives
	March 31, 2019				December 31, 2018				September 30, 2019			December 31, 2018
(In thousands)	(Unaudited)				December 31, 2018				(Unaudited)
	Balance Sheet Location	Fair Value			Balance Sheet Location	Fair Value
	Balance Sheet Location	Fair Value			Balance Sheet Location	Fair Value			Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments
Foreign exchange contracts - ST forwards	Other current liabilities	$	(763	)	Other current liabilities	$	(662	)	Prepaid expenses and other current assets	$	11,855	Prepaid expenses and other current assets	$	7,594

Foreign exchange contracts - LT forwards	Other long-term liabilities	(225		)	Other long-term liabilities	(191		)	Other long-term assets	3,480		Other long-term assets	1,380
Total derivatives designated as hedging instruments		$	(988	)		$	(853	)		$	15,335		$	8,974

Derivatives not designated as hedging instruments

Foreign exchange contracts - ST forwards	Other current liabilities	$	(473	)	Other current liabilities	$	(630	)	Prepaid expenses and other current assets	$	262	Prepaid expenses and other current assets	$	395
Total derivatives not designated as hedging instruments		$	(473	)		$	(630	)		$	262		$	395

Total derivatives		$	(1,461	)		$	(1,483	)		$	15,597		$	9,369



	Liability Derivatives
	September 30, 2019				December 31, 2018
(In thousands)	(Unaudited)				December 31, 2018
	Balance Sheet Location	Fair Value			Balance Sheet Location	Fair Value
	Balance Sheet Location	Fair Value			Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments
Foreign exchange contracts - ST forwards	Other current liabilities	$	(3,461	)	Other current liabilities	$	(662	)

Foreign exchange contracts - LT forwards	Other long-term liabilities	(2,362		)	Other long-term liabilities	(191		)
Total derivatives designated as hedging instruments		$	(5,823	)		$	(853	)

Derivatives not designated as hedging instruments

Foreign exchange contracts - ST forwards	Other current liabilities	$	(459	)	Other current liabilities	$	(630	)
Total derivatives not designated as hedging instruments		$	(459	)		$	(630	)

Total derivatives		$	(6,282	)		$	(1,483	)

The following tables present the effect of derivative instruments on our Consolidated Statements of Income for three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, respectively:


March 31, 2019
September 30, 2019							September 30, 2019
(In thousands)															(Unaudited)
Derivatives in Cash Flow Hedging Relationship	Gain or (Loss) Recognized in OCI on Derivative			Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Gain or (Loss) Reclassified from Accumulated OCI into Income			Gain or (Loss) Recognized in OCI on Derivative			Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Gain or (Loss) Reclassified from Accumulated OCI into Income
Foreign exchange contracts - forwards	$	1,800		Net sales	$	1,745		$	6,736		Net sales	$	3,291

Foreign exchange contracts - forwards	(270		)	Cost of sales	20			(2,946		)	Cost of sales	(176		)

Foreign exchange contracts - forwards	(318		)	Operating expenses	29			(2,163		)	Operating expenses	(112		)
Total	$	1,212			$	1,794		$	1,627			$	3,003


March 31, 2018
September 30, 2018								September 30, 2018
(In thousands)															(Unaudited)
Derivatives in Cash Flow Hedging Relationship	Gain or (Loss) Recognized in OCI on Derivative			Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Gain or (Loss) Reclassified from Accumulated OCI into Income				Gain or (Loss) Recognized in OCI on Derivative			Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Gain or (Loss) Reclassified from Accumulated OCI into Income
Foreign exchange contracts - forwards	$	(5,073	)	Net sales	$	(2,620	)		$	3,569		Net sales	$	1,424

Foreign exchange contracts - forwards	726			Cost of sales	341				(96		)	Cost of sales	74

Foreign exchange contracts - forwards	576			Operating expenses	456				(157		)	Operating expenses	111
Total	$	(3,771	)		$	(1,823	)		$	3,316			$	1,609



(In thousands)
Derivatives not Designated as Hedging Instruments	Location of Gain (Loss) Recognized in Income	Amount of Gain (Loss) Recognized in Income		Amount of Gain (Loss) Recognized in Income
		September 30, 2019		September 30, 2018
		(Unaudited)		(Unaudited)
Foreign exchange contracts - forwards	Net foreign exchange gain/(loss)	$	287	865

Total		$	287	$	865

The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the nine months ended September 30, 2019 and 2018, respectively:



September 30, 2019
(In thousands)
(Unaudited)
Derivatives in Cash Flow Hedging Relationship	Gain or (Loss) Recognized in OCI on Derivative			Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Gain or (Loss) Reclassified from Accumulated OCI into Income
Foreign exchange contracts - forwards	$	7,186		Net sales	$	7,687

Foreign exchange contracts - forwards	(3,386		)	Cost of sales	(217		)

Foreign exchange contracts - forwards	(2,441		)	Operating expenses	(158		)
Total	1,359				$	7,312



September 30, 2018
(In thousands)
(Unaudited)
Derivatives in Cash Flow Hedging Relationship	Gain or (Loss) Recognized in OCI on Derivative			Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Gain or (Loss) Reclassified from Accumulated OCI into Income
Foreign exchange contracts - forwards	$	16,128		Net sales	$	(2,491	)

Foreign exchange contracts - forwards	(2,422		)	Cost of sales	717

Foreign exchange contracts - forwards	(2,128		)	Operating expenses	888
Total	$	11,578			$	(886	)


(In thousands)
Derivatives not Designated as Hedging Instruments	Location of Gain (Loss) Recognized in Income	Amount of Gain (Loss) Recognized in Income			Amount of Gain (Loss) Recognized in Income			Location of Gain (Loss) Recognized in Income	Amount of Gain (Loss) Recognized in Income			Amount of Gain (Loss) Recognized in Income
		March 31, 2019			March 31, 2018				September 30, 2019			September 30, 2018
		(Unaudited)			(Unaudited)				(Unaudited)			(Unaudited)
Foreign exchange contracts - forwards	Net foreign exchange gain/(loss)	$	(228	)	(1,761		)	Net foreign exchange gain/(loss)	$	(82	)	678

Total		$	(228	)	$	(1,761	)		$	(82	)	$	678

໿

Note 6 – Inventories, net

Inventories, net consist of the following:



	September 30, 2019		December 31,
(In thousands)	(Unaudited)		2018

Raw materials	$	107,270	$	98,346
Work-in-process	11,589		9,306
Finished goods	87,868		86,494
Total	$	206,727	$	194,146

March 31, 2019 December 31,
(In thousands) (Unaudited) 2018

Raw materials $ 102,186
$ 98,346
Work-in-process 9,708
9,306
Finished goods 92,816
86,494
$ 204,710
$ 194,146

໿

Note 7 – Intangible assets, ~~and goodwill~~net

Intangible assets at ~~March 31,~~September 30, 2019 and December 31, 2018 are as follows:



	September 30, 2019
(In thousands)	(Unaudited)							December 31, 2018
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Capitalized software development costs	$	125,787	$	(64,710	)	$	61,077	$	123,842	$	(49,299	)	$	74,543
Acquired technology	91,430		(86,676		)	4,754		92,236		(84,962		)	7,274
Patents	35,503		(23,213		)	12,290		34,427		(21,725		)	12,702
Other	44,251		(31,210		)	13,041		46,437		(30,173		)	16,264
Total	$	296,971	$	(205,809	)	$	91,162	$	296,942	$	(186,159	)	$	110,783

March 31, 2019
(In thousands) (Unaudited) December 31, 2018
Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount
Capitalized software development costs $ 125,857
$ (55,785 ) $ 70,072
$ 123,842
$ (49,299 ) $ 74,543
Acquired technology 91,901
(85,502 ) 6,399
92,236
(84,962 ) 7,274
Patents 34,542
(22,213 ) 12,329
34,427
(21,725 ) 12,702
Other 46,214
(30,948 ) 15,266
46,437
(30,173 ) 16,264
$ 298,514
$ (194,448 ) $ 104,066
$ 296,942
$ (186,159 ) $ 110,783

Software development costs capitalized for the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018 were ~~$2.4~~$2.8 million and ~~$8.0~~$1.9 million, respectively, and related amortization expense was $7.1 million and $6.9 million, respectively. For the nine months ended September 30, 2019 and ~~$6.2~~2018, capitalized software development costs were $7.5 million and $13.8 million, respectively, and related amortization expense was $20.9 million and $19.9 million, respectively. Capitalized software development costs for the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018 included costs related to ~~stock based~~stock-based compensation of $0.2 million and $0.1 million, respectively. For the nine months ended September 30, 2019 and 2018, capitalized software development costs included costs related to stock-based compensation of $0.3 million and $0.6 million, respectively. The related amounts in the table above are net of fully amortized assets.

Amortization of capitalized software development costs is computed on an individual product basis for those products available for market and is recognized based on the product’s estimated economic life, generally three to six years. Acquired technology and other intangible assets are amortized over their useful lives, which range from three to eight years. Patents are amortized using the straight-line method over their estimated period of benefit, generally 10 to 17 years. Total intangible assets amortization expenses were ~~$9.0~~$9.2 million and ~~$8.4~~$9.0 million for the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, respectively, and $27.3 million and $26.4 million for the nine months ended September 30, 2019 and 2018, respectively.

Goodwill

The carrying amount of goodwill as of ~~March 31,~~September 30, 2019, was as follows:



	Amount
	(In thousands)
Balance as of December 31, 2018	$	264,530
Foreign currency translation impact	(5,100		)
Balance as of September 30, 2019 (unaudited)	$	259,430

Amount
(In thousands)
Balance as of December 31, 2018 $ 264,530
Foreign currency translation impact (2,146 )
Balance as of March 31, 2019 (unaudited) $ 262,384

The excess purchase price over the fair value of assets acquired is recorded as goodwill. As we have ~~one~~1 operating segment comprised of components with similar economic characteristics, we allocate goodwill to ~~one~~1 reporting unit for goodwill impairment testing. Goodwill is tested for impairment on an annual basis, and between annual tests if indicators of potential impairment exist, using a fair-value-based approach based on the market capitalization of the reporting unit. Our annual impairment test is performed in the fourth quarter of each year.

NoNaN impairment of goodwill was identified during the ~~three~~nine months ended ~~March 31,~~September 30, 2019 or the twelve months ended December 31, 2018.

Note 8 – Leases

We have operating leases for corporate offices, automobiles, and certain equipment. Our leases have remaining terms of 1 year to 95 years, some of which may include options to extend the leases for up to 9 years, and some of which may include options to terminate the leases within 1 year. Leases with an initial term of 12 months or less are not recorded on the balance ~~sheet; we~~sheet. We recognize lease expense for these leases on a straight-line basis over the lease term.

Amounts related to finance lease activities and income from leasing activities were not material for the periods presented.

The components of operating lease expense were as follows (unaudited):


			Three Months Ended		Nine Months Ended
(In thousands)	March 31, 2019		September 30, 2019
Operating Lease Cost (a)	$	5,725	$	5,456	$	16,951
(a) includes variable and short-term lease costs

Supplemental cash flow information related to operating leases were as follows (unaudited):



	Three Months Ended		Nine Months Ended
(In thousands)	September 30, 2019		September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	4,097	$	13,071
Supplemental non-cash information:
Operating lease right-of-use assets obtained in exchange for new operating lease obligations	$	750	$	9,886



~~(In thousands)~~	~~March 31, 2019~~
~~Cash paid for amounts included in the measurement of lease liabilities:~~
~~Operating cash flows from operating leases~~	~~4,791~~

~~Supplemental non-cash information:~~
~~Operating lease right-of-use assets obtained in exchange for new operating lease obligations~~	~~6,334~~

Maturities of lease liabilities as of ~~March 31,~~September 30, 2019 were as follows (unaudited):



(In thousands)
Years ending December 31,	Operating Leases
2019 (Excluding the nine months ended September 30, 2019)	$	4,590
2020	15,008
2021	10,176
2022	6,835
2023	5,272
Thereafter	13,649
Total future minimum lease payments	55,530
Less imputed interest	(8,380		)
Total	$	47,150

Weighted Average Remaining Lease Term (years)
Operating Leases	5.09

Weighted Average Discount Rate
Operating Leases	5.1		%

(In thousands)
Years ending December 31, Operating Leases
2019 (Excluding the three months ended March 31, 2019) $ 15,280
2020 15,295
2021 10,512
2022 7,573
2023 6,669
Thereafter 14,936
Total future minimum lease payments 70,265
Less imputed interest (16,023 )
Total $ 54,242

Weighted Average Remaining Lease Term (years)
Operating Leases 5.22

Weighted Average Discount Rate
Operating Leases 6.0 %

As of ~~March 31,~~September 30, 2019, we have additional operating leases, that have not commenced during the period, which were not material.

Note 9 – Income taxes

We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established when necessary to reduce deferred tax assets to amounts which are more likely than not to be realized. We had a valuation allowance of $80 million at ~~March 31,~~September 30, 2019 and December 31, 2018. A majority of the valuation allowance is related to the deferred tax assets of National Instruments Hungary Kft. (“NI Hungary”).

We account for uncertainty in income taxes recognized in our financial statements using prescribed recognition thresholds and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on our tax returns. We had ~~$8.0~~$7.6 million and $9.8 million of unrecognized tax benefits at ~~March 31,~~September 30, 2019 and December 31, 2018, respectively, all of which would affect our effective income tax rate if recognized. We recorded a gross increase in unrecognized tax benefits of ~~$0.2~~$0.7 million and $1.1 million for the three ~~month period~~and nine months ended ~~March 31,~~September 30, 2019, respectively, as a result of the tax positions taken during ~~this period.~~these and prior periods. We recorded a gross decrease in unrecognized tax benefits of ~~$2.0~~$1.5 million and $3.6 million for the three ~~month period~~and nine months ended ~~March 31,~~September 30, 2019, respectively, as a result of closing of open tax years. As of ~~March 31,~~September 30, 2019, it is reasonably possible that we will recognize tax benefits in the amount of ~~$1.5~~$2.8 million in the next twelve months due to the closing of open tax years. The nature of the uncertainty is related to deductions taken on returns that have not been examined by the applicable tax authority. Our continuing policy is to recognize interest and penalties related to income tax matters in income tax expense. As of ~~March 31,~~September 30, 2019, we had approximately ~~$0.7~~$0.6 million accrued for interest related to uncertain tax positions. The tax years 2012 through 2019 remain open to examination by the major taxing jurisdictions to which we are subject.

Our provision for income taxes reflected an effective tax rate of ~~11%~~23% and ~~18%~~11% for the three ~~month period~~months ended ~~March 31,~~September 30, 2019 and 2018, respectively, and 18% and 13% for the nine months ended September 30, 2019 and 2018, respectively. For the three ~~month period~~months ended ~~March 31,~~September 30, 2019, our effective tax rate was higher than the U.S. federal statutory rate of 21% as a result of state income taxes, the U.S. tax on global intangible low-taxed income, nondeductible officer compensation, and an adjustment to the one-time transition tax on deferred foreign income, offset by the research and development tax credit, an enhanced deduction for certain research and development expenses, a decrease in unrecognized tax benefits resulting from the closing of open tax years, and the deduction for foreign-derived deduction eligible income. For the nine months ended September 30, 2019, our effective tax rate was lower than the U.S. federal statutory rate of 21% as a result of an enhanced deduction for certain research and development expenses, ~~profits in foreign jurisdictions with reduced income tax rates, the deduction for foreign-derived deduction eligible income,~~ a decrease in unrecognized tax benefits resulting from the closing of open tax years, the research and development tax credit, ~~and~~excess tax benefits from share-based compensation, a tax benefit from disqualifying dispositions of equity awards that do not ordinarily result in a tax benefit and the deduction for foreign-derived deduction eligible income, offset by state income taxes, the U.S. tax on global intangible low-taxed income, ~~and~~ nondeductible officer ~~compensation.~~compensation, and an adjustment to the one-time transition tax on deferred foreign income. For the three ~~month period~~and nine months ended ~~March 31,~~September 30, 2018, our effective tax rate was lower than the U.S. federal statutory rate of 21% as a result of an enhanced deduction for certain research and development expenses, profits in foreign jurisdictions with reduced income tax rates, the ~~deduction for foreign-derived deduction eligible income, the~~ research and development tax credit, ~~and~~excess tax benefits from share-based compensation, a tax benefit from disqualifying dispositions of equity awards that do not ordinarily result in a tax benefit, the deduction for foreign-derived deduction eligible income, and an adjustment to the one-time transition tax on deferred foreign income, offset by the U.S. tax on global intangible low-taxed income.

Our earnings in Hungary are subject to a statutory tax rate of 9%. In addition, our research and development activities in Hungary benefit from a tax law in Hungary that provides for an enhanced deduction for qualified research and development expenses. The tax position of our Hungarian operations resulted in income tax benefits of ~~$1.0~~$1.6 million and ~~$1.7~~$2.6 million for the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, respectively, and $4.2 million and $7.1 million for the nine months ended September 30, 2019 and 2018, respectively.

Earnings from our operations in Malaysia are free of tax under a tax holiday effective January 1, 2013. This tax holiday expires in 2027. If we fail to satisfy the conditions of the tax holiday, this tax benefit may be terminated early. The income tax benefits of the tax holiday for the three and nine months ended ~~March 31,~~September 30, 2019 were approximately $1.8 million and ~~March 31,~~$3.1 million, respectively. The income tax benefits of the tax holiday for the three and nine months ended September 30, 2018 were approximately ~~$0.5~~$0.8 million and ~~$0.6~~$1.9 million, respectively. The impact of the tax holiday on a per share basis for each of the three and nine months ended ~~March 31,~~September 30, 2019 was a benefit of $0.01 and ~~March 31,~~$0.02, respectively. The impact of the tax holiday on a per share basis for each of the three and nine months ended September 30, 2018 was a benefit of ~~$0.01 per share.~~$0.01.

No other taxing jurisdictions had a significant impact on our effective tax rate. We have not entered into any advanced pricing or other agreements with the IRS with regard to any foreign jurisdictions.

Note 10 – Comprehensive income

Our comprehensive income is comprised of net income, foreign currency translation, unrealized gains and losses on forward contracts and securities classified as available-for-sale. The accumulated OCI, net of tax, for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 and 2018, consisted of the following:


	March 31, 2019												September 30, 2019
	(Unaudited)												(Unaudited)
(In thousands)	Currency translation adjustment			Investments			Derivative instruments			Accumulated other comprehensive income/(loss)			Currency translation adjustment			Investments			Derivative instruments			Accumulated other comprehensive income/(loss)
Balance as of December 31, 2018	$	(22,485	)	$	(1,308	)	6,862			$	(16,931	)	$	(22,485	)	$	(1,308	)	6,862			$	(16,931	)
Current-period other comprehensive income (loss)	(3,067		)	1,175			3,006			1,114
Current-period other comprehensive (loss) income													(9,303		)	1,494			8,671			862
Reclassified from accumulated OCI into income	—			—			(1,794		)	(1,794		)	—			—			(7,312		)	(7,312		)
Income tax benefit (expense)	—			(6		)	216			210
Balance as of March 31, 2019	$	(25,552	)	$	(127	)	$	7,858		$	(17,821	)
Income tax expense (benefit)													—			(11		)	366			355
Balance as of September 30, 2019													$	(31,788	)	$	197		$	7,855		$	(23,736	)



	September 30, 2018
	(Unaudited)
(In thousands)	Currency translation adjustment			Investments			Derivative instruments			Accumulated other comprehensive income/(loss)
Balance as of December 31, 2017	$	(12,717	)	$	(782	)	(3,010		)	$	(16,509	)
Current-period other comprehensive income (loss)	(7,360		)	(404		)	10,692			2,928
Reclassified from accumulated OCI into income	—			—			886			886
Income tax expense	—			30			2,449			2,479
Balance as of September 30, 2018	$	(20,077	)	$	(1,216	)	$	6,119		$	(15,174	)

March 31, 2018
(Unaudited)
(In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss)
Balance as of December 31, 2017 $ (12,717 ) $ (782 ) (3,010 ) $ (16,509 )
Current-period other comprehensive income (loss) 5,804
(696 ) (5,594 ) (486 )
Reclassified from accumulated OCI into income —
—
1,823
1,823
Income tax benefit (expense) —
(65 ) (807 ) (872 )
Balance as of March 31, 2018 $ (6,913 ) $ (1,413 ) $ (5,974 ) $ (14,300 )

໿

Note 11 – Authorized shares of common and preferred stock and stock-based compensation plans

Authorized shares of common and preferred stock

Following approval by the Company’s Board of Directors and stockholders, on May 14, 2013, the Company’s certificate of incorporation was amended to increase the authorized shares of common stock by 180,000,000 shares to a total of 360,000,000 shares. As a result of this amendment, the total number of shares which the Company is authorized to issue is 365,000,000 shares, consisting of (i) 5,000,000 shares of preferred stock, par value $0.01 per share, and (ii) 360,000,000 shares of common stock, par value $0.01 per share.

Restricted stock plan

Our stockholders approved our 2005 Incentive Plan (the “2005 Plan”) in May 2005. At the time of approval, 4,050,000 shares of our common stock were reserved for issuance under this plan, as well as the number of shares which had been reserved but not issued under our 1994 Incentive Plan (the “1994 Plan”) which terminated in May 2005, ~~(the “1994 Plan”),~~ and any shares that returned to the 1994 Plan as a result of termination of options or repurchase of shares issued under such plan. The 2005 Plan, administered by the Compensation Committee of the Board of Directors, provided for granting of incentive awards in the form of restricted stock and RSUs to directors, executive officers and employees of the Company and its subsidiaries. Awards vest over a three, five or ten-year period, beginning on the date of grant. Vesting of ~~ten year~~ten-year awards may accelerate based on ~~the Company’s~~our previous year’s earnings and growth but ~~ten year~~ten-year awards cannot accelerate to vest over a period of less than five years. The 2005 Plan terminated on May 11, 2010, except with respect to outstanding awards previously granted thereunder. There were 3,362,304 shares of common stock that were reserved but not issued under the 2005 Plan as of May 11, 2010.

Our stockholders approved our 2010 Incentive Plan (the “2010 Plan”) on May 11, 2010. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under this plan, as well as the 3,362,304 shares of common stock that were reserved but not issued under the 1994 Plan and the 2005 Plan as of May 11, 2010, and any shares that are returned to the 1994 Plan and the 2005 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under these plans. The 2010 Plan, administered by the Compensation Committee of the Board of Directors, provides for granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants ~~of the Company~~ and employees and consultants of any ~~parent or subsidiary of the Company.~~subsidiary. Awards vest over a three, five or ten-year period, beginning on the date of grant. Vesting of ~~ten year~~ten-year awards may accelerate based on ~~the Company’s~~our previous year’s earnings and growth but ~~ten year~~ten-year awards cannot accelerate to vest over a period of less than five years. The 2010 Plan terminated on May 12, 2015, except with respect to the outstanding awards previously granted thereunder. There were 2,518,416 shares of common stock that were reserved but not issued under the 2010 Plan as of May 12, 2015.

Our stockholders approved our 2015 Equity Incentive Plan (the “2015 Plan”) on May 12, 2015. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under this plan, as well as the 2,518,416 shares of common stock that were reserved but not issued under the 2010 Plan as of May 12, 2015, and any shares that were returned to the 1994, 2005, and the 2010 Plans as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under these plans. The 2015 Plan, administered by the Compensation Committee of the Board of Directors, provides for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants ~~of the Company~~ and employees and consultants of any ~~parent or~~ subsidiary ~~of the Company~~ and such awards may be subject to performance-based vesting conditions. Awards vest over a three, four, five or ten-year period, beginning on the date of grant. Vesting of ~~ten year~~ten-year awards may accelerate based on ~~the Company’s~~our previous year’s earnings and growth but ~~ten year~~ten-year awards cannot accelerate to vest over a period of less than five years. There were ~~2,705,610~~1,934,762 shares available for grant under the 2015 Plan at ~~March 31,~~September 30, 2019.

During the ~~three month period~~nine months ended ~~March 31,~~September 30, 2019, we granted PRSUs to certain executives under our 2015 Plan. Refer to the "Summary of Significant Accounting Policies" in Note 1 - Basis of presentation for additional discussion regarding the impact of these ~~new~~ grants on our accounting policies and related estimates.

Employee stock purchase plan

Our employee stock purchase plan permits substantially all domestic employees and employees of designated subsidiaries to acquire our common stock at a purchase price of 85% of the lower of the market price at the beginning or the end of the purchase period. The plan has quarterly purchase periods generally beginning on February 1, May 1, August 1 and November 1 of each year. Employees may designate up to 15% of their compensation for the purchase of common stock under this plan. On May ~~9, 2017,~~14, 2019, our stockholders approved an additional 3,000,000 shares for issuance under our employee stock purchase plan. At ~~March 31,~~September 30, 2019, we had ~~1,749,934~~4,295,207 shares of common stock reserved for future issuance under this plan. We issued ~~245,110~~699,837 shares under this plan in the ~~three~~nine months ended ~~March 31,~~September 30, 2019 and the weighted average purchase price ~~of the shares issued~~ was ~~$37.59~~$36.90 per share. During the ~~three~~nine months ended ~~March 31,~~September 30, 2019, we did not make any changes in accounting principles or methods of estimates with respect to such plan.

Authorized Preferred Stock and Preferred Stock Purchase Rights Plan

We have 5,000,000 authorized shares of preferred stock. On January 21, 2004, our Board of Directors designated 750,000 of these shares as Series A Participating Preferred Stock in conjunction with the adoption of a Preferred Stock Rights Agreement which expired on May 10, 2014. There were no0 shares of preferred stock issued and outstanding at ~~March 31,~~September 30, 2019.

Stock repurchases and retirements

From time to time, our Board of Directors has authorized various programs for our repurchase of shares of our common stock depending on market conditions and other factors. Under the current program, during the three months ended September 30, 2019, we repurchased ~~1,035,098~~1,056,078 shares of our common stock at a weighted average price per share at $42.42 and during the nine months ended September 30, 2019, we repurchased 3,205,676 shares of our common stock at a weighted average price per share of ~~$44.83 during the three months ended March 31, 2019.~~$42.79. We did not ~~make~~repurchase any ~~repurchases~~shares during the ~~three~~nine months ended ~~March 31,~~September 30, 2018. At ~~March 31,~~September 30, 2019, there were ~~2,964,902~~794,324 shares remaining available for repurchase under this program. This repurchase program does not have an expiration date.

Note 12 –Segment and geographic information

We operate as ~~one~~1 operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is our chief executive officer, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker evaluates our financial information and resources and assesses the performance of these resources on a consolidated basis. Since we operate in ~~one~~1 operating segment, all required financial segment information can be found in the condensed consolidated financial statements and the notes thereto.

We sell our products in ~~three~~3 geographic regions which consist of ~~Americas; Europe, Middle East, India,~~Americas, EMEIA and ~~Africa (EMEIA); and Asia-Pacific (APAC).~~APAC. Our sales to these regions share similar economic characteristics, similar product mix, similar customers, and similar distribution methods. Revenue from the sale of our products, which are similar in nature, and software maintenance is reflected as total net sales in our Consolidated Statements of Income. (See Note 2 ~~–Revenue~~- Revenue of Notes to ~~consolidated financial statements~~Consolidated Financial Statements for total net sales by the major geographic areas in which we operate).

Based on the billing location of the customer, total sales outside the U.S. for the three months ended ~~March 31,~~September 30, 2019 and 2018 were ~~$198~~$208 million and ~~$200~~$213 million, respectively, and $617 million and $635 million for the nine months ended September 30, 2019 and 2018, respectively. Total property and equipment, net, outside the U.S. was ~~$115~~$126 million as of September 30, 2019 and $132 million ~~as of March 31, 2019 and~~at December 31, ~~2018. See Note 1 - Basis of presentation for additional information regarding~~2018, respectively. Revenues and long-lived assets attributable to each individual foreign country outside the ~~impact of the new lease accounting standard on our consolidated balance sheet.~~U.S. were not material.

Note 13 - Debt

On May 9, 2013, we entered into a Loan Agreement (the “Loan Agreement”) with Wells Fargo Bank (the “Lender”). The Loan Agreement provided for a $50 million unsecured revolving line of credit with a scheduled maturity date of May 9, 2018 (the ~~“Maturity~~“Original Maturity Date”). On October 29, 2015, we entered into a First Amendment to Loan Agreement (the “Amendment”) with the Lender, which amended our Loan Agreement to among other things, (i) increase the unsecured revolving line of credit from $50 million to $125 million, (ii) extend the Original Maturity Date of the line of credit from May 9, 2018 to October 29, 2020 (the "Amended Maturity Date"), and (iii) provide us with an option to request increases to the line of credit of up to an additional $25 million in the aggregate, subject to consent of the Lender and terms and conditions to be mutually agreed between us and the Lender. On April 27, 2018, we entered into a Second Amendment to Loan Agreement (the "Second Amendment") which amended the Loan Agreement, as amended by the Amendment to, among other things, (i) reduce the revolving line of credit from $125.0 million to $5.0 million, (ii) reduce the letter of credit sublimit under the line of credit from $10.0 million to $5.0 million and (iii) require us and our subsidiaries to comply with certain of the affirmative and negative covenants under the Loan Agreement only if loans are outstanding under the Loan Agreement or if we have not reimbursed any drawing under a letter of credit issued under the Loan Agreement within five business days following the request of the Lender.

The loans bear interest, at our option, at a base rate determined in accordance with the Loan Agreement, plus a spread of 0.0% to 0.50%, or a LIBOR rate plus a spread of 1.13% to 2.00%, in each case with such spread determined based on a ratio of consolidated indebtedness to EBITDA, determined in accordance with the Loan Agreement. Principal, together with all accrued and unpaid interest, is due and payable on the Amended Maturity Date. We are also obligated to pay a quarterly commitment fee, payable in arrears, based on the available commitments at a rate of 0.18% to 0.30%, with such rate determined based on the ratio described above. The Loan Agreement contains customary affirmative and negative covenants. The affirmative covenants include, among other things, delivery of financial statements, compliance certificates and notices; payment of taxes and other obligations; maintenance of existence; maintenance of properties and insurance; and compliance with applicable laws and regulations. The negative covenants include, among other things, limitations on indebtedness, liens, mergers, consolidations, acquisitions and sales of assets, investments, changes in the nature of the business, affiliate transactions and certain restricted payments. The Loan Agreement also requires us to maintain a ratio of consolidated indebtedness to EBITDA equal to or less than 3.25 to 1.00, and a ratio of consolidated EBITDA to interest expense greater than or equal to 3.00 to 1.00, in each case determined in accordance with the Loan Agreement. As of ~~March 31,~~September 30, 2019, we were in compliance with all applicable covenants in the Loan Agreement.

The Loan Agreement contains customary events of default including, among other things, payment defaults, breaches of covenants or representations and warranties, cross-defaults with certain other indebtedness, bankruptcy and insolvency events, judgment defaults and change in control events, subject to grace periods in certain instances. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Loan Agreement. Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default under the Loan Agreement at a per annum rate of interest equal to 2.00% above the otherwise applicable interest rate.

Proceeds of loans made under the Loan Agreement may be used for working capital and other general corporate purposes. We may prepay the loans under the Loan Agreement in whole or in part at any time without premium or penalty. Certain of our existing and future material domestic subsidiaries are required to guaranty our obligations under the Loan Agreement.

As of ~~March 31,~~September 30, 2019, we had no0 outstanding borrowings under this line of credit. During the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and September 30, 2018, we incurred no0 interest ~~expense under this line of credit.~~expense. As of ~~March 31,~~September 30, 2019 and ~~March 31,~~September 30, 2018, the weighted-average interest rate on the revolving line of credit was ~~3.7%~~3.2% and ~~3.0%~~3.4%, respectively.

Note 14 – Commitments and contingencies

We offer a one-year limited warranty on most hardware products which is included in the terms of sale of such products. We also offer optional extended warranties on our hardware products for which the related revenue is recognized ratably over the warranty period. Provision is made for estimated future warranty costs at the time of the sale for the estimated costs that may be incurred under the standard warranty. Our estimate is based on historical experience and product sales during the period. The warranty reserve for the ~~three month periods~~nine months ended ~~March 31,~~September 30, 2019 and 2018 was as follows:

Three Months Ended March 31,
(In thousands) (Unaudited)
2019 2018
Balance at the beginning of the period $ 3,173
$ 2,846
Accruals for warranties issued during the period 626
729
Accruals related to pre-existing warranties (133 ) 230
Settlements made (in cash or in kind) during the period (515 ) (784 )
Balance at the end of the period $ 3,151
$ 3,021



	Nine Months Ended September 30,
(In thousands)	(Unaudited)
	2019			2018
Balance at the beginning of the period	$	3,173		$	2,846
Accruals for warranties issued during the period	1,665			2,224
Accruals related to pre-existing warranties	(441		)	335
Settlements made (in cash or in kind) during the period	(1,899		)	(2,235		)
Balance at the end of the period	$	2,498		$	3,170

As of ~~March 31,~~September 30, 2019, we had non-cancelable purchase commitments with various suppliers of customized inventory and inventory components totaling approximately ~~$7.1~~$6.4 million over the next twelve months. ~~As of March 31, 2019, we had no outstanding guarantees for payment of customs and foreign grants, which are generally payable over the next twelve months.~~

Note 15 – Restructuring

Since the first quarter of 2017, we have been taking steps to ~~reduce~~optimize our ~~overall employee headcount in an effort to minimize~~processes, reduce job duplication, or evaluate where we should shift and centralize activities, improve efficiencies, and rebalance our resources on higher return activities. The timing and scope of our headcount reductions will vary.

A summary of the charges in ~~the~~our consolidated statement of operations resulting from our restructuring activities is shown below:



	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	(Unaudited)				(Unaudited)
	2019		2018		2019		2018
Cost of sales	$	—	(179	)	$	—	(150	)
Research and development	34		631		690		1,607
Sales and marketing	2,993		3,676		7,958		8,354
General and administrative	990		373		2,512		1,538
Total restructuring and other related costs	$	4,017	4,501		$	11,160	11,349

Three Months Ended March 31,
(In thousands) (Unaudited)
2019 2018
Cost of sales $ —
28
Research and development 345
146
Sales and marketing 1,981
1,645
General and Administration 990
612
Total restructuring and other related costs $ 3,316
2,431

A summary of ~~balance sheet~~balances and activity related to ~~the~~our restructuring activity is shown below:



	Restructuring Liability
	(in thousands)
Balance as of December 31, 2018	$	3,506
Income statement expense	11,160
Cash payments	(10,503		)
Balance as of September 30, 2019	$	4,163

Restructuring Liability
(in thousands)
Balance as of December 31, 2018 $ 3,506
Income statement expense 3,316
Cash payments (3,178 )
Balance as of March 31, 2019 $ 3,644

The restructuring liability of ~~$3.6~~$4.2 million at ~~March 31,~~September 30, 2019 relating to ~~this~~our restructuring activity is recorded in the “accrued compensation” line item of ~~the~~our consolidated balance sheet.

໿

Note 16 – Litigation

We are not currently a party to any material litigation. However, in the ordinary course of our business, we have in the past, are currently and will likely become involved in various legal proceedings, claims, and regulatory, tax or government inquiries and investigations, and could incur uninsured liability in any one or more of them. We also periodically receive notifications from various third parties related to alleged infringement of patents or intellectual property rights, commercial disputes or other matters. No assurances can be given with respect to the extent or outcome of any investigation, litigation or dispute.

Note 17 – Subsequent events

On ~~April 24,~~October 23, 2019, our Board of Directors declared a quarterly cash dividend of $0.25 per common share, payable on ~~June 3,~~December 2, 2019, to stockholders of record on ~~May 13,~~November 11, 2019.

On October 23, 2019, our Board of Directors amended our stock repurchase program to increase the number of shares that may be repurchased by 3 million shares.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements contained herein regarding our future financial performance, operations or other matters (including, without limitation, statements to the effect that we “believe,” ~~"expect," "plan," "intend~~“expect,” “plan,” “intend to,~~" "may," "will,~~” ~~"project,"~~“may,” “will,” “project,” “anticipate,” ~~"continue,"~~“continue,” “are encouraged by,” "are cautious", "are optimistic", or ~~"estimate"~~“estimate”; statements of ~~"goals"~~“goals” or ~~"visions"~~“visions”; or other variations thereof or comparable terminology or the negative thereof) should be considered forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of important factors, including those set forth under the heading “Risk Factors” beginning on page~~42,~~ 46, and in the discussion below. Readers are also encouraged to refer to the documents regularly filed by us with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2018, for further discussion of our business and the risks attendant thereto.

Overview

For more than 40 years, National Instruments Corporation (the ~~"Company"~~“Company”, ~~"we"~~“we”, ~~"us"~~“us” or ~~"our"~~“our”) has enabled engineers and scientists around the world to accelerate productivity, innovation and discovery. Our software-centric platform provides an advanced approach through integration of software and modular hardware to create automated test and automated measurement systems. We believe our long-term track record of innovation and our differentiated platform help support the success of our customers, employees, suppliers and stockholders. We have been profitable in every year since 1990. We sell to a large number of customers in a wide variety of industries.

The key strategies that we focus on in running our business are the following:

Expanding our broad customer base

We strive to increase our already broad customer base and to grow our large order business by serving a large market on many computer platforms, through a global marketing and distribution network. We also seek to acquire new technologies and expertise from time to time to open new opportunities for our existing product portfolio.

Maintaining a high level of customer satisfaction

To maintain a high level of customer satisfaction we strive to offer innovative, modular and integrated products through a global sales and support network. We strive to maintain a high degree of backwards compatibility across different platforms to preserve the customer’s investment in our products. In this time of intense global competition, we believe that it is crucial that we continue to offer products with high quality and reliability, and that our products provide cost-effective solutions for our customers.

Leveraging external and internal technology

Our product strategy is to provide superior products by leveraging generally available technology, supporting open architectures on multiple platforms and leveraging our core technologies across multiple products.

We sell ~~into~~automated test and automated measurement ~~and industrial/embedded applications~~systems in a broad range of industries and are subject to the economic and industry forces that drive those markets. It has been our experience that the performance of these industries and our performance are impacted by general trends in industrial production for the global economy and by the specific performance of certain vertical markets that are intensive consumers of measurement technologies. Examples of these markets are advanced research, ~~automotive,~~ automated test equipment, ~~consumer electronics,~~automotive, commercial aerospace, computers and electronics, consumer electronics, continuous process manufacturing, education, government/defense, medical research/pharmaceutical, power/energy, semiconductors, and telecommunications.

Leveraging a worldwide sales, distribution and manufacturing network

We distribute and sell our software and hardware products primarily through a direct sales organization. We also use independent distributors, original equipment manufacturers, value-added resellers, system integrators, and consultants to market and sell our products. We have sales offices in the U.S. and sales offices and distributors in key international markets. Sales outside of the Americas accounted for approximately ~~61%~~58% and ~~62%~~59% of our net sales during the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, respectively, and approximately 60% and 61% of our net sales during the nine months ended September 30, 2019 and 2018, respectively. The vast majority of our foreign sales are denominated in the customers’ local currency, which exposes us to the effects of changes in foreign currency exchange rates. We expect that a significant portion of our total net sales will continue to be derived from international sales. (See Note 2 –- Revenue of Notes to ~~consolidated financial statements~~Consolidated Financial Statements for details concerning the geographic breakdown of our net sales).

We manufacture substantially all of our product volume at our facilities in Debrecen, Hungary and Penang, Malaysia. Our product manufacturing operations can be divided into four areas: electronic circuit card and module assembly; chassis and cable assembly; technical manuals and product support documentation; and software duplication. Most of our electronic circuit card assemblies, modules and chassis are manufactured in house, although contractors are used from time to time. The majority of our electronic cable assemblies are produced by contractors; however, we do manufacture some on an exception basis. Our software duplication, technical manuals and product support documentation are primarily produced by contractors.

Delivering high quality, reliable products

We believe that our long-term growth and success depend on delivering high quality software and hardware products on a timely basis. Accordingly, we focus significant efforts on research and development. We focus our research and development efforts on enhancing existing products and developing new products that incorporate appropriate features and functionality to be competitive with respect to technology, price and performance. Our success also depends on our ability to obtain and maintain patents and other proprietary rights related to technologies used in our products. We have engaged in litigation and where necessary, will likely engage in future litigation to protect our intellectual property rights. In monitoring and policing our intellectual property rights, we have been and may be required to spend significant resources.

Our operating results fluctuate from period to period due to changes in global economic conditions and a number of other factors. As a result, we believe our historical results of operations should not be relied upon as indications of future performance. There can be no assurance that our net sales will grow, or not decline, or that we will remain profitable in future periods.

Current business outlook

Many of the industries we serve have historically been cyclical and have experienced periodic downturns. In assessing our business, we consider the trends in the Global Purchasing Managers’ Index (“PMI”), global industrial production as well as industry reports on the specific vertical industries that we target. Historically, our business cycles have generally followed the expansion and contraction cycles in the global industrial economy as measured by the Global PMI. InFor the three ~~month period~~months ended ~~March 31,~~September 30, 2019, the average of the Global PMI was ~~50.7 which is indicative of expansion in the industrial sector,~~49.5 and the average of the new order element of the Global PMI was 49.2. For the nine months ended September 30, 2019, the average of the Global PMI was 50.0 ~~which~~and the average of the new order element of the Global PMI was 49.6. A Global PMI of 50.0 is a neutral ~~reading.~~ rating, a number greater than 50.0 is indicative of expansion and a number less than 50.0 is indicative of contraction.

We ~~are unable~~continue to ~~predict whether~~face headwinds related to global trade tensions and softening demand as a result of the slowdown in the global industrial ~~economy, as measured by~~economy. These factors could have an adverse effect on the ~~PMI, will remain at or above the neutral reading~~spending patterns of ~~50, strengthen or contract during the remainder~~businesses, including our current and potential customers, which could negatively impact our revenues and results of ~~2019.~~

operations. We remain cautious about economic uncertainty indicated by these headwinds along with the ~~weakening PMI during early 2019. However, we are encouraged by our continuing commitment~~weakened Global PMI. We remain committed to operational excellence and the disciplined execution of our long-term ~~goals, reflected by recent improvements in our operational profitability. Additionally,~~growth strategy and we remain optimistic about ~~our strategic objectives for the company and~~ our long-term position in the industry through our differentiated software-centric platform and the ~~sustained differentiation~~increased system-level value we deliver to our customers ~~through our platform-based approach. Despite the weakening PMI, we continue~~ to see growth in our orders above $20,000 which we believe reflects our focus on developing highly differentiated products, particularly for complex test and measurement systems. In the first quarter of 2019, we saw a 6% year over yearhelp them decrease ~~from orders under $20,000, which was offset by a 6% year over year increase from orders over $20,000.~~their time to market.

Since the first quarter of 2017, we have been taking steps to optimize our processes, reduce ~~our overall employee headcount in an effort to~~job duplication, evaluate where we should shift and centralize activities, improve efficiencies, and rebalance our resources on higher return activities. We incurred $2$3 million in severance and other restructuring-related charges, net of tax during the three months ended ~~March 31,~~September 30, 2019. The timing and scope of any future headcount reductions will vary.

During ~~early~~the three and nine months ended September 30, 2019, we saw ~~a slightly appreciated U.S~~continued volatility in the exchange rates between the U.S. dollar ~~index with a mix~~and many of ~~appreciation and devaluation in~~ the currency markets where we ~~do business. In~~have exposure. This volatility had a negative impact on our net sales and results of operations for the ~~markets where we have our largest exposure to foreign currency,~~three and nine months ended September 30, 2019. As of the ~~Eurozone and China,~~date of this filing, the U.S. dollar ~~appreciated against~~index, as tracked by the ~~Euro by approximately 2% and devalued against the Chinese yuan by approximately 2%.~~St. Louis Federal Reserve, remains near its ten-year high. See “Results of Operations” below for additional discussion on the impact of foreign exchange rates on our business for the three ~~month period~~and nine months ended ~~March 31,~~September 30, 2019. See “Our Revenues are Subject to Seasonal Variations” under “Risk Factors” for additional discussion of potential fluctuations in our net sales.

We have hedging programs in place to help mitigate the risks associated with foreign currency ~~risks.~~exchange rate fluctuations. However, there can be no assurance ~~such~~the hedges will offset more than a portion of the financial impact resulting from movements in the foreign currency markets in which we do business. (See Note 5 – Derivative instruments and hedging activities of Notes to ~~consolidated financial statements~~Consolidated Financial Statements for additional details concerning our hedging programs.)

Results of Operations

The following table sets forth, for the periods indicated, the percentage of net sales represented by certain items reflected in our Consolidated Statements of Income:


	Three Months Ended March 31,				Three Months Ended September 30,				Nine Months Ended September 30,
	(Unaudited)				(Unaudited)				(Unaudited)
	2019		2018		2019		2018		2019		2018
Net sales:
Americas	39.4	%	38.4	%	42.0	%	41.3	%	40.0	%	39.3	%
EMEIA	31.8		33.8		28.1		28.7		29.8		31.5
APAC	28.8		27.8		29.9		30.0		30.2		29.2
Total net sales	100.0		100.0		100.0		100.0		100.0		100.0
Cost of sales	24.5		23.9		25.2		25.7		24.9		24.6
Gross profit	75.5		76.1		74.8		74.3		75.1		75.4
Operating expenses:
Sales and marketing	37.8		38.5		33.5		34.2		35.7		36.6
Research and development	21.3		19.8		19.6		19.1		20.4		19.5
General and administrative	9.0		8.7		10.5		7.7		9.4		8.2
Gain on sale of asset					(7.9	)	—		(2.7	)	—
Total operating expenses	68.0		67.1		55.6		61.0		62.8		64.3
Operating income	7.5		9.0		19.1		13.3		12.3		11.1
Other income (expense):
Interest income	0.7		0.3		0.6		0.4		0.6		0.4
Net foreign exchange loss	0.1		0.3		(0.1	)	(0.3	)	(0.2	)	(0.2	)
Other income, net	—		(0.2	)
Other gain (loss), net					0.2		0.5		0.1		—
Income before income taxes	8.4		9.4		19.8		14.0		12.8		11.3
Provision for income taxes	0.9		1.7		4.6		1.5		2.3		1.4
Net income	7.5	%	7.8	%	15.2	%	12.5	%	10.5	%	9.9	%

Figures may not sum due to rounding.

Results of Operations for the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and 2018

Net Sales. The following table sets forth our net sales for the three ~~month periods ending March 31,~~and nine months ended September 30, 2019 and 2018 along with the changes between the corresponding periods.


	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
	(Unaudited)						(Unaudited)						(Unaudited)
					Change						Change						Change
(In millions)	2019		2018		Dollars	Percentage	2019		2018		Dollars	Percentage	2019		2018		Dollars	Percentage

Product sales	$	277.7	$	280.4	(2.7)	(1)%	$	305.2	$	310.2	(5.0)	(2)%	$	882.7	$	897.4	(14.6)	(2)%
Software maintenance sales	33.4		31.5		1.8	6%	35.2		35.9		(0.7)	(2)%	103.0		101.7		1.3	1%
Total net sales	$	311.1	$	311.9	(0.8)	—	$	340.4	$	346.1	(5.7)	(2)%	$	985.7	$	999.0	(13.3)	(1)%

Figures may not sum due to rounding.

The slight decreases in our net sales during the three and nine month periods ended September 30, 2019 were primarily related to the adverse impact of changes in foreign currency exchange rates. Orders with a value greater than $20,000 ~~increased~~decreased by 6%4% year over year during the three months ended ~~March 31,~~September 30, 2019, compared to the year over year increase of ~~7% in the three month period ended March 31, 2018. A significant factor in the continued expansion of our large orders~~21% in the three months ended ~~March 31,~~September 30, 2018. During the nine months ended September 30, 2019, ~~was strong demand for our system-level offerings, particularly~~orders with a value greater than $20,000 decreased by 1% year over year compared to the year over year increase of 16% in applications related to semiconductor validation and production test. The increase in software maintenance sales was primarily related to recent growth in our software offerings, and consequently, billings for annual renewals of software maintenance programs during the ~~trailing 12 months.~~nine months ended September 30, 2018.

During the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, ~~large~~orders over $20,000 were 60% and 59% of our total orders, respectively, and for the nine months ended September 30, 2019 and 2018, these orders were 59% and ~~56%~~58% of our total orders, respectively. Orders with a value greater than $20,000, particularly those orders with a value greater than $100,000, are more volatile, are subject to greater discount variability, and may contract at a faster pace during an economic downturn compared to our other orders.

The following table sets forth our net sales by geographic region for the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and 2018 along with the changes between the corresponding periods and the region’s percentage of total net sales.


	Three Months Ended March 31,								Three Months Ended September 30,								Nine Months Ended September 30,
	(Unaudited)								(Unaudited)								(Unaudited)
							Change								Change								Change
(In millions)	2019			2018			Dollars	Percentage	2019			2018			Dollars	Percentage	2019			2018			Dollars	Percentage

Americas	$	122.7		$	119.7		2.9	2%	$143.1			$	142.9		0.2	—%	$	394.7		$	392.4		2.3	1%
Percentage of total net sales	39.4		%	38.4		%			42.0		%	41.3		%			40.0		%	39.3		%

EMEIA	98.8			$	105.4		(6.6)	(6)%	95.7			$	99.4		(3.7)	(4)%	293.5			314.9			(21.3)	(7)%
Percentage of total net sales	31.8		%	33.8		%			28.1		%	28.7		%			29.8		%	31.5		%

APAC	$	89.6		$	86.8		2.8	3%	$	101.6		$	103.8		(2.2)	(2)%	297.5			291.7			5.8	2%
Percentage of total net sales	28.8		%	27.8		%			29.9		%	30.0		%			30.2		%	29.2		%

Figures may not sum due to rounding.

We expect sales outside of the Americas to continue to represent a significant portion of our net sales. We intend to continue to expand our international operations by increasing our presence in existing markets, adding a presence in some new geographical markets and continuing the use of distributors to sell our products in some countries. Almost all of the sales made by our direct sales offices in the Americas (excluding the U.S.), EMEIA, and APAC are denominated in local currencies, and accordingly, the U.S. dollar equivalent of these sales is affected by changes in foreign currency exchange rates. In order to provide a framework for assessing how our underlying business performed excluding the effects of foreign currency fluctuations between periods, we compare the percentage change in our results from period to period using constant currency disclosure. To calculate the change in constant currency, current and comparative prior period results for entities reporting in currencies other than U.S. Dollars are converted into U.S. Dollars at constant exchange rates (i.e., the average rates in effect during the three ~~month period~~and nine months ended ~~March 31,~~September 30, 2018). The following ~~table presents~~tables present this information, along with the impact of changes in foreign currency exchange rates on sales denominated in local currencies, for the three ~~month period~~and nine months ended ~~March 31,~~September 30, 2019.



	Three Months Ended September 30, 2018		Change in Constant Dollars			Impact of changes in foreign currency exchange rates on net sales			Three Months Ended September 30, 2019
(In millions)	GAAP Net Sales		Dollars		Percentage	Dollars		Percentage	GAAP Net Sales

Americas	$	142.9	0.3		0.2%	(0.1	)	(0.1)%	$	143.1
EMEIA	$	99.4	(2.0	)	(2.0)%	(1.7	)	(1.7)%	$	95.7
APAC	$	103.8	—		—%	(2.2	)	(2.1)%	$	101.6
Total net sales	$	346.1	(1.7	)	(0.5)%	(4.0	)	(1.2)%	$	340.4


	Nine Months Ended September 30, 2018		Change in Constant Dollars			Impact of changes in foreign currency exchange rates on net sales			Nine Months Ended September 30, 2019
(In millions)	GAAP Net Sales		Dollars		Percentage	Dollars		Percentage	GAAP Net Sales

Americas	$	392.4	3.0		0.8%	(0.8	)	(0.2)%	$	394.7
EMEIA	$	314.9	(12.8	)	(4.1)%	(8.5	)	(2.7)%	$	293.5
APAC	$	291.7	13.1		4.5%	(7.3	)	(2.5)%	$	297.5
Total net sales	$	999.0	3.3		0.3%	(16.6	)	(1.7)%	$	985.7

Three Months Ended March 31, 2018
Change
in Constant Dollars
Impact of changes in foreign currency exchange rates on net sales Three Months Ended March 31, 2019
(In millions)
GAAP
Net Sales
Dollars Percentage Dollars Percentage
GAAP
Net Sales

Americas $ 119.7
3.2
2.7% (0.3 ) (0.3)% 122.7
EMEIA $ 105.4
(3.4 ) (3.2)% (3.2 ) (3.0)% 98.8
APAC $ 86.8
5.4
6.2% (2.6 ) (3.0)% 89.6
Total net sales $ 311.9
5.3
1.7% (6.1 ) (1.9)% 311.1

Figures may not sum due to rounding.

To help protect against changes in U.S. dollar equivalent value caused by fluctuations in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales, we ~~have instituted~~maintain a foreign currency cash flow hedging program. We hedge portions of our forecasted net sales denominated in foreign currencies with average rate forward contracts. During the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, these hedges had the effect of increasing our net sales by ~~$1.7~~$3.3 million and increasing our net sales by $1.4 million, respectively. During the nine months ended September 30, 2019 and 2018, these hedges had the effect of increasing our net sales by $7.7 million and decreasing our net sales by ~~$2.6~~$2.5 million, respectively. (See Note 5 - Derivative instruments and hedging activities of Notes to ~~consolidated financial statements~~Consolidated Financial Statements for further discussion regarding our cash flow hedging program and its related impact on our net sales for 2019 and 2018).

Gross Profit. Our gross profit as a percentage of sales is impacted by many factors including changes in the amount of revenues from our large customers and changes in the foreign currency exchange markets. We continue to focus on cost control and cost reduction measures throughout our manufacturing cycle. The following table sets forth our gross profit and gross profit as a percentage of net sales for the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and 2018 along with the percentage changes in gross profit for the corresponding periods.


	Three Months Ended March 31,		Three Months Ended September 30,		Nine Months Ended September 30,
	(Unaudited)		(Unaudited)		(Unaudited)

(In millions)	2019	2018	2019	2018	2019	2018

Gross Profit	$235.0	$237.4	$254.5	$257.1	$740.0	$753.3
% change compared with prior period	(1.0)%		(1.0)%		(1.8)%
Gross Profit as a percentage of net sales	75.5%	76.1%	74.8%	74.3%	75.1%	75.4%

The decreases in our gross profit during the three and nine months ended September 30, 2019, compared to the same periods in 2018 are primarily attributable to lower net sales. The increase in our gross profit as a percentage of net sales for the three months ended September 30, 2019, compared to the same period in 2018 is primarily attributable to lower restructuring charges partially offset by unfavorable changes in foreign currency exchange rates. The decrease in our gross profit as a percentage of net sales for the nine months ended September 30, 2019, compared to the same period in 2018 is primarily attributable to unfavorable changes in foreign currency exchange rates. For the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, the change in exchange rates had the effect of decreasing our cost of sales by ~~$1.3~~$0.7 million and increasing our cost of sales by ~~$2.0~~$0.02 million, respectively. For the nine months ended September 30, 2019 and 2018, the change in exchange rates had the effect of decreasing our cost of sales by $3.6 million and increasing our cost of sales by $4.0 million, respectively. To help protect against changes in our cost of sales caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows, we have a foreign currency cash flow hedging program. We hedge portions of our forecasted costs of sales denominated in foreign currencies with average rate forward contracts. During the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, these hedges had the effect of ~~decreasing~~increasing our cost of sales by ~~less than $0.1~~$0.2 million and decreasing our cost of sales by ~~$0.3~~$0.1 million, respectively. During the nine months ended September 30, 2019 and 2018, these hedges had the effect of increasing our cost of sales by $0.2 million and decreasing our cost of sales by $0.7 million, respectively. (See Note 5 - Derivative instruments and hedging activities of Notes to Consolidated Financial Statements for further discussion regarding our cash flow hedging program and its related impact on our cost of sales for 2019 and 2018).

~~During the three months ended March 31, 2019 our backlog increased by $10 million.~~ We do not typically maintain a large amount of order backlog as orders typically translate to sales quickly. As such, any weakness in orders typically has a pronounced impact on our net sales in the short term.

Operating Expenses. The following table sets forth our operating expenses for the three ~~month periods~~and nine months ended ~~March 31,~~September 30, 2019 and 2018, along with the percentage changes between the corresponding periods and the line item as a percentage of total net sales.


	Three Months Ended March 31,							Three Months Ended September 30,						Nine Months Ended September 30,
	(Unaudited)							(Unaudited)						(Unaudited)
(In thousands)	2019			2018			Change	2019			2018		Change	2019			2018		Change

Sales and marketing	$	117,551		$	120,117		(2)%	$	113,922		$	118,220	(4)%	$	352,340		$	365,474	(4)%
Percentage of total net sales	38		%	39		%		33%			34%			36%			37%

Research and development	$	66,166		61,843			7%	$	66,558		$	66,170	1%	$	200,981		$	194,921	3%
Percentage of total net sales	21		%	20		%		20%			19%			20%			20%

General and Administrative	$	27,883		27,277			2%
General and administrative								$	35,711		$	26,712	34%	$	92,639		$	81,882	13%
Percentage of total net sales								10%			8%			9%			8%

Gain on sale of assets								$	(26,842	)	$	—	100%	$	(26,842	)	$	—	100%
Percentage of total net sales	9		%	9		%		(8)%			—%			(3)%			—%

Total operating expenses	$	211,600		209,237			1%	$	189,349		$	211,102	(10)%	$	619,118		$	642,277	(4)%
Percentage of total net sales	68		%	67		%		56%			61%			63%			64%

As previously disclosed, on August 29, 2019, we sold Millennium Property and recognized a gain on the sale of $26.8 million, which is presented as "Gain on sale of assets" on the Consolidated Statements of Income.

The year over year increase of $5 million in our operating expenses, excluding the gain on sale of assets, during the three months ended September 30, 2019 was primarily related to the following:

•$7 million increase due to a charitable contribution to a donor-advised fund using a portion of

the proceeds from the sale of the Millennium Property;

•$4 million increase due to additional stock-based compensation expense, primarily attributable to comparatively higher stock prices on the grant date of unvested RSU awards and a shorter average service period for our awards;

•$2 million decrease related to the year over year impact of changes in foreign currency exchange rates;

•$3 million decrease in personnel costs, primarily attributable to a decrease in variable compensation cost; and

•$1 million decrease in restructuring costs.

The year over year increase in our general and administrative expenses is primarily related to the charitable contribution discussed above.

The year over year decrease in our operating expenses, excluding the gain on sale of assets, during the ~~three month period ending March 31,~~nine months ended September 30, 2019 was primarily related to the following:

•$11 million decrease related to the year over year impact of changes in foreign currency exchange rates;

•$10 million increase due to additional stock-based compensation expense, primarily attributable to

comparatively higher stock prices on the grant date of unvested RSU awards and a $4shorter average service period

for our awards;

•$7 million increase due to a charitable contribution to a donor-advised fund using a portion of

the proceeds from the sale of the Millennium Property;

•$7 million decrease in personnel costs, primarily attributable to a decrease in variable compensation costs;

•$6 million increase in our research and development expenses, primarily attributable to a decrease in our software

development costs eligible for capitalization, as described in more detail ~~below.~~below; and

~~a $4~~•$1 million decrease ~~related to the year over year impact of changes~~ in ~~foreign currency exchange rates~~

~~a slight decrease in personnel costs, primarily attributable to a decrease in salary~~marketing and benefits costs due to lower headcount, mostly offset by a $3 million increase related to our equity compensation costs related to higher stock prices on the grant date of our restricted stock unit awards; and

~~a $1 million increase in miscellaneous costs related to~~ outside ~~services, trade shows, and special events~~service costs.

WeIn the three months ended September 30, 2019, we capitalized $2$2.8 million of software development costs ~~in the three month period ended March 31, 2019,~~ compared to $8$1.9 million in the three ~~month period~~months ended March 31, 2018, which had the effect of increasing our operating expenses by $6 million. We believe that our long-term growth and success depends on developing high quality software and hardware products on a timely basis. We are focused on leveraging recent investments in research and development and in our field sales force and taking actions to help ensure that those resources are concentrated in areas and on initiatives that will contribute to future growth in our business.

September 30, 2018. In the second quarter of 2018,we began moving toward more frequent releases for many of our software products. Specifically, for many of our software development projects we started applying agile development methodologies which are characterized by a more dynamic development process with more frequent and iterative revisions to a product release's features and functions as the software is being developed. Due to the shorter development cycle and focus on rapid production associated with agile development, we expect that for a significant majority of our software development projects the costs incurred subsequent to the achievement of technological feasibility will be immaterial in future periods and we expect to record significantly less capitalized software development costs than under our historical software development approaches. Consequently, a larger portion of our software development expenditures have been recognized as operating expenses starting in the second quarter of 2018. We also expect amortization of previously capitalized software development costs will begin to steadily decline as previously capitalized software development costs become fully amortized over the next ~~three to~~ four years.

We believe that our long-term growth and success depends on developing high quality software and hardware products on a timely basis. We are focused on leveraging our investments in research and development and in our field sales force and taking actions to help ensure that those resources are concentrated in areas and on initiatives that will contribute to future growth in our business.

Operating Income. For the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, operating income was ~~$23~~$65 million and ~~$28~~$46 million, respectively, ~~a decrease~~an increase of ~~17%~~42%. As a percentage of net sales, operating income was ~~7.5%~~19.1% and ~~9.0%~~13.3% for the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, respectively. For the nine months ended September 30, 2019 and 2018, operating income was $121 million and $111 million, respectively, an increase of 9%. As a percentage of net sales, operating income was 12.3% and 11.1% for the nine months ended September 30, 2019 and 2018, respectively. The ~~decrease~~increase in operating income in absolute dollars for the three ~~month period~~months ended ~~March 31,~~September 30, 2019, compared to the three ~~month period~~months ended ~~March 31,~~September 30, 2018, isand for the nine months ended September 30, 2019, compared to the nine months ended September 30, 2018, are attributable to the factors discussed in Net Sales, Gross Profit and Operating Expenses above.

Interest Income.For the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, interest income was ~~$2.2~~$1.9 million and ~~$1.0~~$1.5 million, respectively. ~~We are seeing improving~~For the nine months ended September 30, 2019 and 2018, interest income was $6.2 million and $3.8 million, respectively. During 2019, the federal reserve cut the Federal Funds Rate which resulted in declines in the yields for high quality investment alternatives ~~that~~(that comply with our corporate investment ~~policy. We expect yields in these types~~policy), and could negatively impact the amount of ~~investments to remain near current levels during~~interest income from our investment portfolio for the remainder of 2019.

Net Foreign Exchange ~~Gain/(Loss).~~Loss.For the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, net foreign exchange ~~gain/(loss)~~loss was ~~$0.4~~$(0.4) million and ~~$1.0~~$(1.0) million, respectively. During the nine months ended September 30, 2019 and 2018, net foreign exchange loss was $(1.6) million and $(2.1) million, respectively. These results are attributable to movements in the foreign currency exchange rates between the U.S. dollar and foreign currencies in subsidiaries for which our functional currency is not the U.S. dollar. ~~During~~For the first ~~quarter~~nine months of 2019, we saw ~~a slightly appreciated U.S~~continued volatility in the exchange rates between the U.S. dollar ~~index with a mix~~and many of ~~appreciation and devaluation in~~ the currency markets where we do business. As of the date of this filing, the U.S. dollar index, as tracked by the St. Louis Federal Reserve, remains near its ten-year high although it has declined slightly since December 31, 2018.have exposure. In the past, we have noted that ~~significant~~ volatility in the foreign currency exchange markets in which we do business has had a significant impact on the revaluation of our foreign currency denominated firm commitments, on our ability to forecast our U.S. dollar equivalent net sales and expenses and on the effectiveness of our hedging programs.We cannot predict to what degree foreign currency markets will fluctuate in the ~~future.In~~future. In the past, these dynamics have also adversely affected our net sales growth in international markets and may pose similar challenges in the future. We recognize the local currency as the functional currency in virtually all of our international subsidiaries. See “Results of Operations - Net Sales” above for additional discussion on the impact of foreign exchange rates on our net sales of operations for the three and nine months ended September 30, 2019.

We utilize foreign currency forward contracts to hedge our foreign denominated net foreign currency balance sheet positions to help protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically hedge up to 90% of our outstanding foreign denominated net receivable or payable positions and typically limit the duration of these foreign currency forward contracts to approximately 90 days. The gain or loss on these derivatives as well as the offsetting gain or loss on the hedged item attributable to the hedged risk is recognized in current earnings under the line item “Net foreign exchange ~~gain.~~loss.” Our hedging strategy decreased our foreign exchange ~~gain~~loss by ~~$(0.2)~~$0.3 million and ~~$(1.8)~~decreased our foreign exchange loss by $0.9 million in the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and September 30, 2018, respectively. Our hedging strategy increased our foreign exchange loss by $0.1 million and decreased our foreign exchange loss by $0.7 million in the nine months ended September 30, 2019 and 2018, respectively. (See Note 5 - Derivative instruments and hedging activities of Notes to Consolidated Financial Statements for a further description of our derivative instruments and hedging activities).

Provision for Income Taxes. For the three ~~month periods~~months ended ~~March 31,~~September 30, 2019 and 2018, our provision for income taxes reflected an effective tax rate of ~~11%~~23% and 11%, respectively. For the nine months ended September 30, 2019 and 2018, our provision for income taxes reflected an effective tax rate of 18% and 13%, respectively. The factors that caused our effective tax rate to change year over year are detailed in the table below:



	~~Three Months Ended~~
	~~(Unaudited)~~
~~Effective tax rate at March 31, 2018~~	18	%
~~Change in unrecognized tax benefits~~	(8	)%
~~Other~~	1	%
~~Effective tax rate at March 31, 2019~~	11	%



	Three Months Ended		Nine Months Ended
	September 30, 2019		September 30, 2019
	(Unaudited)		(Unaudited)
Effective tax rate at September 30, 2018	11	%	13	%
Foreign taxes greater than federal statutory rate	3		2
Global intangible low-taxed income inclusion	(1	)	(1	)
Change in unrecognized tax benefits	—		(2	)
Employee share-based compensation	1		1
Research and development tax credit	(2	)	(2	)
State income taxes, net of federal benefit	1		1
Enhanced deduction for certain research and development	1		1
Transition tax on deferred foreign income	8		4
Capital gain on asset sale	1		—
Other	—		1
Effective tax rate at September 30, 2019	23	%	18	%

Other operational metrics

We believe that the following additional unaudited operational metrics assist investors in assessing our operational performance relative to others in our industry and to our historical results. The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition related intangibles, acquisition related transaction costs, restructuring charges, ~~and~~ capitalization and amortization of internally developed software costs, disposal gains on office buildings and related charitable contributions, and other items that were recorded in the line items indicated below (in thousands).

໿


	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
(In thousands)	(Unaudited)
							(Unaudited)						(Unaudited)
	2019			2018			2019			2018			2019			2018
Stock-based compensation
Cost of sales	$	793		$	724		$	904		$	844		$	2,587		$	2,415
Sales and marketing	4,375			3,338			5,231			3,452			14,745			10,408
Research and development	3,550			2,518			4,099			3,318			12,029			9,091
General and administrative	2,316			1,623			3,158			1,942			8,693			5,578
Provision for income taxes	(1,836		)	(1,658		)	(2,128		)	(1,455		)	(7,904		)	(6,115		)
Total	$	9,198		$	6,545		$	11,264		$	8,101		$	30,150		$	21,377


	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
(In thousands)	(Unaudited)
	2019			2018			(Unaudited)						(Unaudited)
Amortization of acquisition intangibles
							2019			2018			2019			2018
Amortization of acquisition-related intangibles
Cost of sales	$	851		$	902		$	833		$	701		$	2,525		$	2,448
Sales and marketing	499			537			492			510			1,485			1,580
Research and development	28			28			28			28			84			84
Other income, net							124			—			285			—
Provision for income taxes	(194		)	(192		)	(190		)	(149		)	(576		)	(518		)
Total	$	1,184		$	1,275		$	1,287		$	1,090		$	3,803		$	3,594

໿


	Three Months Ended March 31,							Three Months Ended September 30,						Nine Months Ended September 30,
(In thousands)	(Unaudited)
	2019			2018				(Unaudited)						(Unaudited)
Acquisition transaction costs and restructuring charges
								2019			2018			2019			2018
Acquisition transaction costs, restructuring charges, and other
Cost of sales	$	—		$	28			$	—		$	1,784		$	—		$	1,813
Sales and marketing	2,143			1,645				2,993			3,676			8,290			8,354
Research and development	345			209				244			692			899			1,794
General and administrative(1)	912			612				7,998			373			9,525			1,538
Gain on sale of asset(1)								$	(26,842	)	$	—		$	(26,842	)	$	—
Other (income) loss, net								—			—			—			709
Provision for income taxes	(840		)	(553		)		3,090			(1,800		)	1,240			(3,983		)
Total	$	2,560		$	1,941			$	(12,517	)	$	4,725		$	(6,888	)	$	10,225
(1): During the third quarter of 2019, we recognized a gain of $27 million related to the sale of the Millennium property, presented within "Gain on sale of assets". During the third quarter of 2019, we also recognized a charitable contribution expense of $7 million related to a donation using a portion of the proceeds from the sale of the property, presented within "General and administrative".							(1): During the third quarter of 2019, we recognized a gain of $27 million related to the sale of the Millennium property, presented within "Gain on sale of assets". During the third quarter of 2019, we also recognized a charitable contribution expense of $7 million related to a donation using a portion of the proceeds from the sale of the property, presented within "General and administrative".


	Three Months Ended March 31,						Three Months Ended September 30,						Nine Months Ended September 30,
	(Unaudited)						(Unaudited)						(Unaudited)
(In thousands)	2019			2018
							2019			2018			2019			2018
Capitalization and amortization of internally developed software costs
Cost of sales	$	6,582		$	5,829		$	6,954		$	6,412		$	20,073		$	18,736
Research and development	(2,280		)	(7,667		)	(2,682		)	(1,808		)	(7,179		)	(13,152		)
Provision for income taxes	(903		)	386			(897		)	(967		)	(2,708		)	(1,173		)
Total	$	3,399		$	(1,452	)	$	3,375		$	3,637		$	10,186		$	4,411

Liquidity and Capital Resources

Overview

At ~~March 31,~~September 30, 2019, we had ~~$480~~$432 million in cash, cash equivalents and short-term investments. Our cash and cash equivalent balances are held in numerous financial institutions throughout the world, including substantial amounts held outside of the U.S., however, ~~the majority~~all of our short-term investments that are located outside of the U.S. are denominated in the U.S. dollar with the exception of $5 million U.S. dollar equivalent of corporate bonds that are denominated in Euro. The following table presents the geographic distribution of our cash, cash equivalents, and short-term investments as of ~~March 31,~~September 30, 2019 (in millions):


	Domestic	International	Total	Domestic	International	Total
Cash and cash equivalents	$53.7	$175.1	$228.8	$80.3	$142.5	$222.8
	23%	77%		36%	64%
Short-term investments	$176.3	$75.0	$251.3	$135.5	$73.9	$209.4
	70%	30%		65%	35%
Total cash, cash equivalents and short-term investments	$230.0	$250.1	$480.1	$215.8	$216.4	$432.2
	48%	52%		50%

The following table presents our working capital, cash and cash equivalents and short-term investments:


	March 31, 2019		December 31,		Increase/			September 30, 2019		December 31,		Increase/
(In thousands)	(unaudited)		2018		(Decrease)			(unaudited)		2018		(Decrease)

Working capital	$	678,263	$	739,236	$	(60,973	)	$	636,443	$	739,236	$	(102,793	)
Cash and cash equivalents (1)	228,766		$	259,386	(30,620		)	222,773		259,386		(36,613		)
Short-term investments (1)	251,297		271,396		(20,099		)	209,416		271,396		(61,980		)
Total cash, cash equivalents and short-term investments	$	480,063	$	530,782	$	(50,719	)	$	432,189	$	530,782	$	(98,593	)

(1) Included in working capital

Our principal sources of liquidity include cash, cash equivalents, and marketable securities, as well as the cash flows generated from our ~~operations~~operations.

The primary ~~drivers~~driver of the net decrease in working capital between December 31, 2018 and ~~March 31,~~September 30, 2019 ~~were:~~

◦~~Cash,~~was the $99 million decrease in total cash, cash equivalents, and short-term ~~investments decreased by $51 million. Additional analysis of the~~investments. Additionally, other changes in ~~our cash flows for the three month period ended March 31, 2019 compared to the three month period ended March 31, 2018 are discussed below.~~working capital were related to:


◦	"Accounts receivable, net" decreased by $19 million. Days sales outstanding (“DSO”) was relatively flat at 64 days at September 30, 2019, and 65 days at December 31, 2018. The decrease in accounts receivable is primarily related to variations in our quarterly net sales.


◦	Inventory increased by $13 million to $207 million at September 30, 2019, from $194 million at December 31, 2018. Inventory turns were 1.7 and 1.8 at September 30, 2019 and December 31, 2018, respectively. The increase in inventory was primarily attributable to lower sales than expected.


◦	Prepaid expenses and other current assets increased by $12 million which was primarily related to an increase in prepaid freight costs and the timing of insurance and maintenance renewals.


◦	Accrued compensation decreased by $3 million which can primarily be attributed to a decrease in payments expected under our company profit sharing and bonus plans.


◦	Accounts payable and accrued expenses increased by $8 million, primarily due to the timing of payments for inventory and other services.


◦	Other current liabilities decreased by $3 million due to the timing and amount of income tax related payments offset by changes in the fair value of certain hedging instruments.

◦Accounts receivable decreased by $28 million. Days sales outstanding increased to 66 days at March 31, 2019, compared to 65 days at December 31, 2018. The decrease in accounts receivable is primarily related to seasonal variations in our quarterly net sales.


◦	Operating lease liabilities, current increased by $14 million which was entirely related to the adoption of the new leasing standard on January 1, 2019, as discussed in Note 1 - Basis of presentation and Note 8 - Leases.

◦Inventory increased by $11 million to $205 million at March 31, 2019, from $194 million at December 31, 2018. Inventory turns were 1.6 and 1.8 at March 31, 2019 and December 31, 2018, respectively. The increase in inventory was primarily attributable to an increase in raw materials and finished goods, related to lower sales volume than anticipated during the first quarter of 2019.

◦~~Prepaid expenses and other current assets increased by $12 million which was primarily related to an increase in prepaid freight costs in addition to the timing of insurance and maintenance renewals.~~

◦~~Accrued compensation decreased by $11 million which can be attributed to payments related to our company profit sharing and bonus plans.~~

◦~~The current portion of deferred revenue increased by $3 million, which was primarily related to the timing of annual renewals of our enterprise licensing agreements.~~

◦Operating lease liabilities, current, increased by $16 million which was entirely related to the adoption of the new leasing standard on January 1, 2019, as discussed in Note 1 - Basis of presentation and Note 8 - Leases.

◦Other taxes payable decreased by $8$4 million ~~primarily~~ related to the timing of payments for VAT and other indirect taxes.

Analysis of Cash Flow

The following table summarizes our cash flow results for the ~~three~~nine months ended ~~March 31,~~September 30, 2019 and 2018.



	Three months ended March 31,						Nine Months Ended September 30,
(In thousands)	(unaudited)						(unaudited)
	2019			2018			2019			2018
Cash provided by operating activities	$	42,147		$	39,983		$	149,345		$	187,337
Cash used in investing activities	(2,048		)	(60,782		)
Cash provided by (used in) investing activities							26,300			(95,426		)
Cash used in financing activities	(70,301		)	(21,577		)	(210,431		)	(66,610		)
Effect of exchange rate changes on cash	(418		)	2,577			(1,827		)	(4,084		)
Net change in cash and cash equivalents	(30,620		)	(39,799		)	(36,613		)	21,217
Cash and cash equivalents at beginning of year	259,386			290,164			259,386			290,164
Cash and cash equivalents at end of period	$	228,766		$	250,365		$	222,773		$	311,381

Operating Activities, Cash provided by operating activities is comprised of net income adjusted for certain non-cash items and changes in working capital. Cash provided by operating activities for the ~~three month period~~nine months ended ~~March 31,~~September 30, 2019 ~~increased~~decreased by $2$38 million compared to the same period in 2018. This was primarily due to an $10 million decrease in net income adjusted for certain non-cash items, including stock-based compensation, depreciation and amortization, and gain on sale of assets, and $25 million related to unfavorable changes in operating assets and liabilities. The changes in operating assets and liabilities primarily related to unfavorable changes in prepaids, taxes, and other liabilities compared to the same period in 2018.

Investing Activities Cash ~~used for~~provided (used in) by investing activities for the ~~three month period~~nine months ended ~~March 31,~~September 30, 2019 ~~decreased~~increased by ~~$59~~$122 million compared to the, same period in 2018. This was primarily attributable to a net sale of short-term investments of ~~$21~~$63 million compared to a net purchase of short-term investments of ~~$42~~$50 million during the same period in 2018 and ~~a $10~~proceeds from the sale of the Millennium Property of $32.5 million, ~~purchase~~partially offset by an increase of ~~an interest~~$20 million in ~~an equity-method investee.~~capital expenditures. The net sale of short-term investments was primarily ~~to fund repurchases of~~driven by funding needs for our ~~common~~ stock ~~under our share~~ repurchase ~~program. The increase in~~activities during 2019. Investing cash outflows ~~used in investing activities was partially offset by a decrease in~~related to capitalized software development ~~costs of $5~~decreased by $6 million compared to the same period in ~~2018.~~2018 due to a decrease in development costs eligible for capitalization related to a recent shift for several of our software projects to a more iterative software development cycle. Due to this change in how we develop these software products, we expect the portion of software development expenditures that will be recognized as research and development expenses when incurred, and consequently, classified as operating cash flows, to increase in future periods.

Financing Activities, Cash used by financing activities increased by ~~$49~~$144 million for the ~~three month period~~nine months ended ~~March 31,~~September 30, 2019 compared to the same period in 2018. This was primarily related to an increase of ~~$46~~$137 million in cash outflows used to repurchase ~~1,035,098~~3.2 million shares of our common stock and ~~a $3~~an $8 million increase in cash outflows related to ~~the increase in~~ our quarterly dividend partially offset by a $1 million increase in proceeds from issuance of our common stock ~~from~~under our employee stock purchase plan. (See Note 11 – Authorized shares of common and preferred stock and stock-based compensation plans of Notes to Consolidated Financial Statements for additional discussion about our equity compensation plans and share repurchase program).

Contractual Cash Obligations. Information related to our contractual obligations as of December 31, 2018 can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Contractual Obligations,” in Part II-Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the SEC on February 21, 2019 (the “2018 Form 10-K”). At ~~March 31,~~September 30, 2019, there were no material changes outside the ordinary course of business to our contractual obligations from those reported in our 2018 Form 10-K. See Note 8 - Leases of Notes to Consolidated Financial Statements for additional information regarding our non-cancellable operating lease obligations as of ~~March 31,~~September 30, 2019.

Loan Agreement. ~~On May 9, 2013, we entered into~~ As amended on April 27, 2018, the Loan Agreement ~~with the Lender. On October 29, 2015, we entered into the Amendment with the Lender, which amended our Loan Agreement to among other things,~~provides for (i) ~~increase the unsecured~~a revolving line of credit ~~from $50.0 million to $125.0 million, (ii) extend the maturity date~~ of the line of credit from May 9, 2018 to October 29, 2020, and (iii) provide us with an option to request increases to the line of credit of up to an additional $25.0 million in the aggregate, subject to consent of the Lender and terms and conditions to be mutually agreed between us and the Lender. On April 27, 2018, we entered into the Second Amendment with the Lender, which amends the Loan Agreement, as amended by the Amendment, to, among other things, (i) reduce the revolving line of credit from $125.0 million to $5.0 million, (ii) ~~reduce the~~a letter of credit sublimit under the line of credit ~~from $10.0 million to~~of $5.0 million, and (iii) ~~require~~requires us and our subsidiaries to comply with certain of the affirmative and negative covenants under the Loan Agreement only if loans are outstanding under the Loan Agreement or if we have not reimbursed any drawing under a letter of credit issued under the Loan Agreement within five business days following the request of the Lender. Proceeds of loans made under the Loan Agreement may be used for working capital and other general corporate purposes. We may prepay the loans under the Loan Agreement in whole or in part at any time without premium or penalty. Certain of our existing and future material domestic subsidiaries are required to guaranty our obligations under the Loan Agreement. (See Note 13 – Debt of Notes to Consolidated Financial Statements for additional details on our revolving line of credit).

Off-Balance Sheet Arrangements.We do not have any off-balance sheet debt. At ~~March 31,~~September 30, 2019, we did not have any relationships with any unconsolidated entities or financial partnerships, such as entities often referred to as structured finance entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we were engaged in such relationships.

Prospective Capital Needs. We believe that our existing cash, cash equivalents and short-term investments, together with cash generated from operations as well as from the purchase of common stock through our employee stock purchase plan, will be sufficient to cover our working capital needs, capital expenditures, investment requirements, commitments, payment of dividends to our stockholders and repurchases of our common stock for at least the next 12 months. ~~The~~Additionally, the enactment of the Tax Cuts and Jobs Act ~~allow~~allows us to repatriate our foreign cash for domestic needs without additional taxation. We may also seek to pursue additional financing or to raise additional funds by seeking an increase in our unsecured revolving line of credit under our Loan Agreement or selling equity or debt to the public or in private transactions from time to time. If we elect to raise additional funds, we may not be able to obtain such funds on a timely basis or on acceptable terms, if at all. If we raise additional funds by issuing additional equity or convertible debt securities, the ownership percentages of our existing stockholders would be reduced. In addition, the equity or debt securities that we issue may have rights, preferences or privileges senior to those of our common stock.

Although we believe that we have sufficient capital to fund our operating activities for at least the next 12 months, our future capital requirements may vary materially from those now planned. We anticipate that the amount of capital we will need in the future will depend on many factors, including:

payment of dividends to our stockholders;

repurchases of our common stock;

required levels of research and development and other operating costs;

our business, product, capital expenditure and research and development plans, and product and technology roadmaps;

acquisitions of other businesses, assets, products or technologies;

the overall levels of sales of our products and gross profit margins;

the levels of inventory and accounts receivable that we maintain;

general economic and political uncertainty and specific conditions in the markets we address, including any volatility in the industrial economy in the various geographic regions in which we do business;

the inability of certain of our customers who depend on credit to have access to their traditional sources of credit to finance the purchase of products from us, which may lead them to reduce their level of purchases or to seek credit or other accommodations from us;

capital improvements for facilities;

~~repurchases of our common stock;~~

our relationships with suppliers and customers; and

the level of stock purchases under our employee stock purchase plan.

Recently Issued Accounting Pronouncements

See Note 1 – Basis of presentation in Notes to Consolidated Financial Statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Changes in currency exchange rates and interest rates are our primary financial market risks. Quantitative and qualitative disclosures about market risk appear in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in Part II of our 2018 Form 10-K and there were no material changes during the ~~three~~nine months ended ~~March 31,~~September 30, 2019 to this information reported in our 2018 Form 10-K.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on an evaluation under the supervision and with the participation of our management, our principal executive officer and our principal financial officer have concluded that our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act were effective as of ~~March 31,~~September 30, 2019, to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

Effective January 1, 2019, we adopted ASU 2016-02, Leases and all of the related amendments. Although the new lease standard is not expected to have a material impact on our operating results on an ongoing basis, we did implement changes to our processes related to lease control activities, including information systems. These included the development of new policies based on identifying leases, determining lease commencement, calculating the present value of leases, determining the incremental borrowing rate and gathering information for required disclosures. There were no other changes in our internal control over financial reporting during the ~~first~~third quarter of 2019, which were identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

~~ITEM~~Item 1. ~~LEGAL PROCEEDINGS~~Legal Proceedings

~~ITEM~~Item 1A. ~~RISK FACTORS~~Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider the risk factors discussed below. The risks described below are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.

Uncertain Global Economic Conditions Could Materially Adversely Affect Our Business and Results of Operations. Our operations and performance are sensitive to fluctuations in general economic conditions, both in the U.S. and globally. Uncertainty about global and regional economic conditions poses a risk to us as businesses may decrease or postpone spending in response to events such as a U.S. government shutdown, the impending Brexit, continued trade tensions between the U.S. and China or other parts of the world, financial market volatility, tariffs or other trade restrictions, government austerity programs, government regulatory actions, negative financial news, geopolitical instability, declines in income or asset values, or other factors. In particular, during December 2018, we experienced weaker demand for some of our products in the APAC region, particularly for applications in China.macroeconomic events. Negative trends or sentiments in worldwide and regional economic conditions have in the past and could again have a material adverse effect on demand for our products and services. In March 2018, the U.S. imposed steel, aluminum, and other tariffs on imports from various countries. These tariffs have increased international trade tensions and led to tariffs on U.S. exports to various countries. Even if resolved, ~~this~~these trends could have a broad negative impact on the global industrial economy, which could have a material adverse impact on our business and our results of operations. These factors as well as others we may not contemplate could have a material adverse effect on the spending patterns of businesses including our current and potential customers which could have a material adverse effect on our net sales and our results of operations. See “Current business outlook” in this Form 10-Q for information regarding recent business conditions.

~~We Make Significant Investments in New Products that May Not Be Successful or Achieve Expected Returns.~~ We plan to continue to make significant investments in research, development, and marketing for new and existing products and technologies. For example, in 2017 we launched LabVIEW NXG, the most recent version of our flagship software application. We have made and expect to make significant investments in software development related to the new and enhanced features of this product. These investments involve a number of risks as the commercial success of such efforts depend on many factors, including our ability to anticipate and respond to innovation, achieve the desired technological fit, and be effective with our marketing and distribution efforts. If our existing or potential customers do not perceive our latest product offerings as providing significant new functionality or value, or if we are late to market with a new product or technology, we may not achieve our expected return on our investments or be able recover the costs expended to develop new product offerings, which could have a material adverse effect on our operating results. Even if our new products are profitable, our operating margins for new products may not be as high as the margins we have experienced historically.

~~Our Success Depends on New Product Introductions and Market Acceptance of Our Products.~~ The market for our products is characterized by rapid technological change, evolving industry standards, changes in customer needs and frequent new product introductions, and is therefore highly dependent upon timely product innovation. Our success is dependent on our ability to successfully develop and introduce new and enhanced products on a timely basis to replace declining revenues from older products, and on increasing penetration in domestic and international markets. As has occurred in the past and as may be expected to occur in the future, we have experienced significant delays between the announcement and the commercial availability of new products. Any significant delay in releasing new products could have a material adverse effect on the ultimate success of a product and other related products and could impede continued sales of predecessor products, any of which could have a material adverse effect on our operating results. There can be no assurance that we will be able to introduce new products in accordance with announced release dates, that our new products will achieve market acceptance or that any such acceptance will be sustained for any significant period. Failure of our new products to achieve or sustain market acceptance could have a material adverse effect on our operating results.

~~Our Reported Financial Results May be Adversely Affected by Changes in Accounting Principles Generally Accepted in the U.S.~~ We prepare our financial statements in conformity with accounting principles generally accepted in the U.S. These accounting principles are subject to interpretation by the FASB and the Securities and Exchange Commission. Generally accepted accounting principles and accompanying accounting pronouncements, implementation guidelines and interpretations for many aspects of our business, such as revenue recognition, software capitalization, and income tax uncertainties, are complex and involve subjective judgments by management. A change in these policies or interpretations could have a significant effect on our reported financial results and our internal controls over financial reporting, may retroactively affect previously reported results, could cause unexpected financial reporting fluctuations, and may require us to make costly changes to our operational processes and accounting systems. For example, in February 2016, the FASB issued ASU 2016-02, Leases, as amended, supersedes nearly all existing U.S. GAAP lease guidance and which became effective for us for our fiscal year beginning January 1, 2019. (See Note 1 - Basis of presentation and Note 8 - Leases for additional discussion of the accounting changes).

We are Subject to Various Risks Associated with International Operations and Foreign Economies. Our international sales are subject to inherent risks, including, but not limited to:

fluctuations in foreign currencies relative to the U.S. dollar;

unexpected changes to currency policy or currency restrictions in foreign jurisdictions;

delays in collecting trade receivable balances from customers in developing economies;

tariffs and other trade barriers;

unexpected changes in regulatory requirements;

fluctuations in local economies;

disparate and changing employment laws in foreign jurisdictions;

difficulties in staffing and managing foreign operations;

costs and risks of localizing products for foreign countries;

government actions throughout the world; and

the burdens of complying with a wide variety of foreign laws.

Moreover, there can be no assurance that our international sales will continue at existing levels or grow in accordance with our efforts to increase foreign market penetration.

In many foreign countries, particularly in those with developing economies, it is common to engage in business practices that are prohibited by U.S. regulations applicable to us such as the Foreign Corrupt Practices Act. Although we have policies and procedures designed to ensure compliance with these laws, there can be no assurance that all of our employees, contractors and agents, including those based in or from countries where practices which violate such U.S. laws may be customary, will not take actions in violation of our policies. Any violation of foreign or U.S. laws by our employees, contractors or agents, even if such violation is prohibited by our policies, could have a material adverse effect on our business. We must also comply with various import and export regulations. The application of these various regulations depends on the classification of our products which can change over time as such regulations are modified or interpreted. As a result, even if we are currently in compliance with applicable regulations, there can be no assurance that we will not have to incur additional costs or take additional compliance actions in the future. Failure to comply with these regulations could result in fines or termination of import and export privileges, which could have a material adverse effect on our operating results. Additionally, the regulatory environment in some countries is very restrictive as their governments try to protect their local economy and value of their local currency against the U.S. dollar.

We Make Significant Investments in New Products that May Not Be Successful or Achieve Expected Returns. We plan to continue to make significant investments in research, development, and marketing for new and existing products and technologies. We have made and expect to make significant investments in software development related to the new and enhanced features of our products. These investments involve a number of risks as the commercial success of such efforts depend on many factors, including our ability to anticipate and respond to innovation, achieve the desired technological fit, and be effective with our marketing and distribution efforts. If our existing or potential customers do not perceive our latest product offerings as providing significant new functionality or value, or if we are late to market with a new product or technology, we may not achieve our expected return on our investments or be able recover the costs expended to develop new product offerings, which could have a material adverse effect on our operating results. Even if our new products are profitable, our operating margins for new products may not be as high as the margins we have experienced historically.

Our Product Revenues are Dependent on Certain Industries and Contractions in these Industries Could Have a Material Adverse Effect on Our Results of Operations. Sales of our products are dependent on customers in certain industries, particularly the telecommunications, semiconductor, consumer electronics, automotive, energy, automated test equipment, and aerospace, defense and government. As we have experienced in the past, and as we may continue to experience in the future, downturns characterized by diminished product demand in any one or more of these industries may result in decreased sales and a material adverse effect on our operating results. We cannot predict when and to what degree contractions in these industries may occur; however, any sharp or prolonged contraction in one or more of these industries could have a material adverse effect on our business and results of operations.

Our Success Depends on New Product Introductions and Market Acceptance of Our Products. The market for our products is characterized by rapid technological change, evolving industry standards, changes in customer needs and frequent new product introductions, and is therefore highly dependent upon timely product innovation. Our success is dependent on our ability to successfully develop and introduce new and enhanced products on a timely basis to replace declining revenues from older products, and on increasing penetration in domestic and international markets. As has occurred in the past and as may be expected to occur in the future, we have experienced significant delays between the announcement and the commercial availability of new products. Any significant delay in releasing new products could have a material adverse effect on the ultimate success of a product and other related products and could impede continued sales of predecessor products, any of which could have a material adverse effect on our operating results. There can be no assurance that we will be able to introduce new products in accordance with announced release dates, that our new products will achieve market acceptance or that any such acceptance will be sustained for any significant period. Failure of our new products to achieve or sustain market acceptance could have a material adverse effect on our operating results.

Our Reported Financial Results May be Adversely Affected by Changes in Accounting Principles Generally Accepted in the U.S. We prepare our financial statements in conformity with accounting principles generally accepted in the U.S. These accounting principles are subject to interpretation by the FASB and the Securities and Exchange Commission. Generally accepted accounting principles and accompanying accounting pronouncements, implementation guidelines and interpretations for many aspects of our business, such as revenue recognition, software capitalization, and income tax uncertainties, are complex and involve subjective judgments by management. A change in these policies or interpretations could have a significant effect on our reported financial results and our internal controls over financial reporting, may retroactively affect previously reported results, could cause unexpected financial reporting fluctuations, and may require us to make costly changes to our operational processes and accounting systems. For example, in February 2016, the FASB issued ASU 2016-02, Leases, and as amended, supersedes nearly all existing U.S. GAAP lease guidance and which became effective for us for our fiscal year beginning January 1, 2019. (See Note 1 - Basis of presentation and Note 8 - Leases in Notes to Consolidated Financial Statements for additional discussion of the accounting changes).

Our Manufacturing Capacity, and a Substantial Majority of our Warehousing and Distribution Capacity is Located Outside of the U.S. We manufacture substantially all of our product volume at our facilities in Debrecen, Hungary and Penang, Malaysia. In order to enable timely shipment of products to our customers we maintain the substantial majority of our inventory at our international locations. In addition to being subject to the risks of maintaining such a concentration of manufacturing capacity and global inventory, these facilities and their operations are also subject to risks associated with doing business internationally, including, but not limited to:

the volatility of the Hungarian forint and the Malaysian ringgit relative to the U.S. dollar;

changing and potentially unstable political environments;

significant and frequent changes in corporate tax laws;

difficulty in managing manufacturing operations in foreign countries;

challenges in expanding capacity to meet increased demand;

difficulty in achieving or maintaining product quality;

interruption to transportation flows for delivery of components to us and finished goods to our customers;

restrictive labor codes; and

increasing labor costs.

No assurance can be given that our efforts to mitigate these risks will be successful. Any failure to effectively deal with the risks above could result in an interruption in the operations of our facilities in Hungary or Malaysia which could have a material adverse effect on our operating results.

Our centralization of inventory and distribution from a limited number of shipping points is subject to inherent risks, including:

burdens of complying with additional or more complex VAT and customs regulations; and

concentration of inventory increasing the risks associated with fire, natural disasters and logistics disruptions to customer order fulfillment.

Any failure or delay in distribution from our facilities in Hungary and Malaysia could have a material adverse effect on our operating results.

Our Financial Performance is Subject to Risks Associated with Changes in the Value of the U.S. Dollar versus Local Currencies. The vast majority of our sales outside of the U.S. are denominated in local currencies, and accordingly, the U.S. dollar equivalent of these sales is affected by changes in the foreign currency exchange rates. If the local currencies in which we sell our products strengthen against the U.S. dollar, we have in the past, and in the future may need to, lower our prices in the local currency to remain competitive in our international markets. This could have a material adverse effect on our gross and net profit margins. If the local currencies in which we sell our products weaken against the U.S. dollar and if the local sales prices cannot be raised due to competitive pressures, we will experience a deterioration of our gross and net profit margins. In the past, we have noted that significant volatility in foreign currency exchange rates in the markets in which we do business has had a significant impact on the revaluation of our foreign currency denominated firm commitments, on our ability to forecast our U.S. dollar equivalent net sales and expenses and on the effectiveness of our hedging programs. In the past, these dynamics have also adversely affected our net sales growth in international markets and may pose similar challenges in the future. See “Results of Operations” in this Form 10-Q for further discussion on the effect that changes in the foreign currency exchange rates have had on our operating results. See “Current business outlook” in this Form 10-Q for information regarding recent business conditions.

Orders ~~With~~with a Value of Greater than One Million Dollars Expose Us to Significant Additional Business and Legal Risks that Could Have a Material Adverse Impact on our Business, Results of Operations and Financial Condition. We continue to make a concentrated effort to increase our net sales through the pursuit of orders with a value greater than $1.0 million. These types of orders expose us to significant additional business and legal risks compared to smaller orders. Our very large customers frequently require contract terms that vary substantially from our standard terms of sale. At times these orders include terms that impose critical delivery commitments and severe contractual liabilities if we fail to provide the required quantity of products at the required delivery times, impose product acceptance requirements and product performance evaluation requirements which create uncertainty with respect to the timing of our ability to recognize revenue from such orders, allow the customers to cancel or delay orders without liability, require us to develop specific product mitigation plans for product delivery constraints caused by unexpected or catastrophic situations to help assure quick production recovery, and that require most favored customer pricing, significant discounts, extended payment terms and volume rebates. At times these customers require broad indemnity obligations and large direct and consequential damage provisions in the event we breach our contracts with them. At times these contracts have supply constraint requirements which mandate that we allocate large product inventories for a specific contract. These inventory requirements expose us to higher risks of inventory obsolescence and can adversely impact our ability to provide adequate product supply to other customers.

While we attempt to limit the number of contracts that contain the non-standard terms of sale described above and attempt to contractually limit our potential liability under such contracts, we have been, and expect to be, required to agree to some or all of such provisions to secure orders from very large customers and to continue to grow our business. These arrangements expose us to significant additional legal and operational risks which could result in a material adverse impact on our business, results of operations and financial condition. In addition, these larger orders are more volatile, are subject to greater discount variability and may contract at a faster pace during an economic downturn. We attempt to manage these risks but there can be no assurance that we will be successful in our efforts.

Revenue Derived from ~~Large~~Systems Orders Could Adversely Affect our Gross Margin and Could Lead to Greater Variability in our Quarterly Results. We ~~define our large order business as~~consider orders with a value greater than ~~$100,000.~~$20,000 as being indicative of our systems business. These orders have been and may continue to be more sensitive to changes in the global industrial economy, subject to greater discount variability and such orders may be pushed-out or reduced at a faster pace during an economic downturn compared to orders valued at less than ~~$100,000.~~$20,000. To the extent that the amount of our net sales derived from ~~large~~systems orders increases in future periods, either in absolute dollars or as a percentage of our overall business, our gross margins could decline, and we could experience greater volatility in our financial results and business, and see a greater negative financial impact from future downturns in the global industrial economy. ~~This dynamic~~Large orders may also have an impact on the historical seasonal pattern of our net sales and our results of operations. ~~These types of~~Large orders ~~also~~ make managing inventory levels more difficult as we have in the past and may have to in the future build large quantities of inventory in anticipation of future demand that may not materialize.

~~Our Product Revenues are Dependent on Certain Industries and Contractions in these Industries Could Have a Material Adverse Effect on Our Results of Operations.~~ Sales of our products are dependent on customers in certain industries, particularly the telecommunications, semiconductor, consumer electronics, automotive, energy, automated test equipment, and ADG. As we have experienced in the past, and as we may continue to experience in the future, downturns characterized by diminished product demand in any one or more of these industries may result in decreased sales and a material adverse effect on our operating results. We cannot predict when and to what degree contractions in these industries may occur; however, any sharp or prolonged contraction in one or more of these industries could have a material adverse effect on our business and results of operations.

Our Realignment Activities May be Disruptive to Our Operations and Negatively Impact Our Results of Operations.

We ~~are currently implementing~~recently implemented changes within our organization designed to enhance our ability to pursue market opportunities, accelerate our technology development initiatives, and improve operational efficiencies. Specifically, we ~~are in the process of aligning~~have aligned certain aspects of our operations with our strategic focus on industry-specific applications where we believe our product platform can add the most value to our customers. In the short-term, these actions may lead to business disruptions, decreased productivity and unanticipated employee turnover which may have an adverse impact on our business and results of operations.

Concentrations of Credit Risk and Uncertain Conditions in the Global Financial Markets May Adversely Affect Our Business and Results of Operations. By virtue of our holdings of cash, investment securities and foreign currency derivatives, we have exposure to many different counterparties, and routinely execute transactions with counterparties in the financial services industry, including commercial banks and investment banks. Many of these transactions expose us to credit risk in the event of a default of our counterparties. We continue to monitor the stability of the financial markets, particularly those in the emerging markets. We can give no assurance that we will not be negatively impacted by any adverse outcomes in those markets. There can be no assurance that any losses or impairments to the carrying value of our financial assets as a result of defaults by our counterparties would not materially and adversely affect our business, financial position and results of operations.

We Have Established a Budget and Variations ~~From~~from Our Budget Will Affect Our Financial Results. We have established an operating budget for fiscal 2019. Our budget was established based on the estimated revenue from sales of our products which are based on anticipated economic conditions in the markets in which we do business as well as the timing and volume of our new products and the expected penetration of both new and existing products in the marketplace. If demand for our products during the remainder of 2019 is less than the demand we anticipated in setting our fiscal year budget, our operating results could be negatively impacted.

If we exceed our budgeted level of expenses or if we cannot reduce expenditures in response to a decrease in net sales, our operating results could be adversely affected. Our spending could exceed our budget due to a number of factors, including, but not limited to:

continued foreign currency fluctuations;

increased manufacturing costs resulting from component supply shortages or component price fluctuations;

additional marketing costs for new product introductions or for conferences and tradeshows;

the timing, cost or outcome of any future intellectual property litigation or commercial disputes;

unanticipated costs related to acquisitions we may make; or

increased component costs resulting from vendors increasing their sales prices.

We Operate in Intensely Competitive Markets. The markets in which we operate are characterized by intense competition from numerous competitors, some of which have larger market capitalization and resources than we do, and we may face further competition from new market entrants in the future. Key competitors are Advantest, Anritsu, Fortive, Keysight, Rohde & Schwarz, Teradyne, and others. These competitors offer hardware and software products that provide solutions that directly compete with our software defined automated test and automated measurement systems. Because these companies have strong positions in the instrumentation business, new product introductions by them, changes in their marketing strategy or product offerings or aggressive pricing strategies by them to gain market share could have a material adverse effect on our operating results.

We believe our ability to compete successfully depends on a number of factors both within and outside our control, including, but not limited to:

general market and economic conditions;

our ability to maintain and grow our business with our very large customers;

our ability to meet the volume and service requirements of our large customers;

success in developing and selling new products;

industry consolidation, including acquisitions by us or our competitors;

capacity utilization and the efficiency of manufacturing operations;

timing of our new product introductions;

new product introductions by competitors;

product pricing, including the impact of currency exchange rates;

the ability of competitors to more fully leverage low cost geographies for manufacturing or distribution;

effectiveness of sales and marketing resources and strategies;

adequate manufacturing capacity and supply of components and materials;

strategic relationships with our suppliers;

product quality and performance;

protection of our products by effective use of intellectual property laws;

the financial strength of our competitors;

the outcome of any future litigation or commercial dispute;

barriers to entry imposed by competitors with significant market power in new markets; and

government actions throughout the world.

There can be no assurance that we will be able to compete successfully in the future.

Our Quarterly Results are Subject to Fluctuations Due to Various Factors that May Adversely Affect Our Business and Results of Operations. Our quarterly operating results have fluctuated in the past and may fluctuate significantly in the future due to a number of factors, including, but not limited to:

~~fluctuations in foreign currency exchange rates;~~

~~changes in global economic conditions;~~

changes in the amount of revenue derived from very large orders (including orders from our very large customers) and the pricing, margins, and other terms of such orders;

tariffs and trade restrictions imposed by the U.S. or other countries;

fluctuations in foreign currency exchange rates;

changes in global economic conditions;

changes in the capacity utilization including at our facility in Malaysia;

changes in the mix of products sold;

the availability and pricing of components from third parties (especially limited sources);

the difficulty in maintaining margins, including the higher margins traditionally achieved in international sales;

changes in pricing policies by us, our competitors or suppliers;

the timing, cost or outcome of any future intellectual property litigation or commercial disputes;

delays in product shipments caused by human error or other factors; or

disruptions in transportation channels.

Our Revenues are Subject to Seasonal Variations. In previous years, our revenues have been characterized by seasonality, with revenues typically growing from the first quarter to the second quarter, being relatively constant from the second quarter to the third quarter, growing in the fourth quarter compared to the third quarter and declining in the first quarter of the following year from the fourth quarter of the preceding year. This historical trend has been affected and may continue to be affected in the future by broad fluctuations in the global industrial economy as well as the timing of new product introductions or any acquisitions. In addition, revenue derived from very large orders, including those from our very large customers, have had a significant impact on our historical seasonal trends as these orders may be more sensitive to changes in the global industrial economy, may be subject to greater volatility in timing and amount, greater discount variability, lower gross margins, and may contract at a faster pace during economic downturns.

Our Tax Returns and Other Tax Matters are Subject to Examination by the U.S. Internal Revenue Service and Other Tax Authorities and Governmental Bodies and the Results of These Examinations Could Have a Material Adverse Effect on Our Financial Condition. We account for uncertainty in income taxes recognized in our financial statements using prescribed recognition thresholds and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on our tax returns. These uncertain tax positions are subject to examination by the U.S. Internal Revenue Service and other tax authorities. There can be no assurance as to the outcome of any future examinations. If the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our operating results, cash flows, and financial condition could be materially adversely affected. Our tax years 2012 through 2019 remain open to examination by the major taxing jurisdictions to which we are subject.

Our Acquisitions are Subject to a Number of Related Costs and Challenges that Could Have a Material Adverse Effect on Our Business and Results of Operations. In recent years, we have completed several acquisitions. Achieving the anticipated benefits of an acquisition depends upon whether the integration of the acquired business, products or technology is accomplished efficiently and effectively. In addition, successful acquisitions generally require, among other things, integration of product offerings, manufacturing operations and coordination of sales and marketing and research and development efforts. These difficulties can become more challenging due to the need to coordinate geographically separated organizations, the complexities of the technologies being integrated, and the necessities of integrating personnel with disparate business backgrounds and combining different corporate cultures. The integration of operations following an acquisition also requires the dedication of management resources, which may distract attention from our day-to-day business and may disrupt key research and development, marketing or sales efforts. Our inability to successfully integrate any of our acquisitions could harm our business. The existing products previously sold by entities we have acquired may be of a lesser quality than our products or could contain errors that produce incorrect results on which users rely or cause failure or interruption of systems or processes that could subject us to liability claims that could have a material adverse effect on our operating results or financial position. Furthermore, products acquired in connection with acquisitions may not gain acceptance in our markets, and we may not achieve the anticipated or desired benefits of such transactions.

Tax Law Changes in Hungary Could Have a Negative Impact on our Effective Tax Rate, Earnings and Results of Operations. The profit from our Hungarian operations benefits from the fact that it is subject to an effective income tax rate that is lower than the U.S. federal statutory tax rate. Our earnings in Hungary are subject to a statutory tax rate of 9%. In addition, effective January 1, 2010, certain qualified research and development expenses in Hungary became eligible for an enhanced tax deduction. These tax benefits may not be available in future years due to changes in political conditions in Hungary or changes in tax laws in Hungary or in the U.S. The reduction or elimination of these benefits in Hungary could result in an increase in our future effective income tax rate which could have a material adverse effect on our operating results. (See Note 9 - Income taxes of Notes to Consolidated Financial Statements for additional discussion regarding the impact of these matters on our income taxes).

Our Income Tax Rate Could be Adversely Affected by the Expiration of a Tax Holiday in Malaysia. Profits from our manufacturing facility in Penang, Malaysia are free of tax under a ~~15 year~~15-year tax holiday effective January 1, 2013. If we fail to satisfy the conditions of the tax holiday, this tax benefit may be terminated early. The expiration of the tax holiday in Malaysia could have a material adverse effect on our operating results. (See Note 9 - Income taxes of Notes to Consolidated Financial Statements for additional discussion regarding the impact of this tax holiday on our income taxes).

Our Business is Dependent on Key Suppliers and Distributors and Disruptions in these Businesses Could Adversely Affect Our Business and Results of Operations. Our manufacturing processes use large volumes of high-quality components and subassemblies supplied by outside sources. Several of these items are only available through limited sources. Limited source items purchased include custom ~~application specific~~application-specific integrated circuits, chassis and other components. We have in the past experienced delays and quality problems in connection with limited source items, and there can be no assurance that these problems will not recur in the future. Accordingly, our failure to receive items from limited source item suppliers could result in a material adverse effect on our net sales and operating results. In the event that any of our limited source suppliers experience significant financial or operational difficulties due to adverse global economic conditions or otherwise, our business and operating results would likely be adversely impacted until we are able to secure another source for the required materials.

In some countries, we use distributors to support our sales channels. In the event that any of our distributors experience significant financial or operational difficulties due to adverse global economic conditions or if we experience disruptions in the use of these distributors, our business and operating results would likely be adversely impacted until we are able to secure another distributor or establish direct sales capabilities in the affected market.

We May Experience Component Shortages that May Adversely Affect Our Business and Result of Operations.As has occurred in the past and as may be expected to occur in the future, supply shortages of components used in our products, including limited source components, can result in significant additional costs and inefficiencies in manufacturing. If we are unsuccessful in resolving any such component shortages in a timely manner, we will experience a significant impact on the timing of revenue, a possible loss of revenue, or an increase in manufacturing costs, any of which would have a material adverse impact on our operating results.

We Rely on Management Information Systems and Interruptions in our Information Technology Systems or Cyber-Attacks on our Systems Could Adversely Affect Our Business. We rely on the efficient and uninterrupted operation of complex information technology systems and networks, including cloud-based and other outsourced services, to operate our business. We rely on a primary global center for our management information systems and on multiple systems in branches not covered by our global center. As with any information system, unforeseen issues may arise that could affect our ability to receive adequate, accurate and timely financial information, which in turn could inhibit effective and timely decisions. Furthermore, it is possible that our global center for information systems or our branch operations could experience a complete or partial shutdown. A significant system or network disruption could be the result of new system implementations, facility issues, energy blackouts, and computer viruses, cyber-attacks, or security breaches, some of which may remain undetected for an extended period. Threats to our information technology security can take a variety of forms and individuals or groups of hackers or sophisticated organizations including state-sponsored organizations, may take steps that pose threats to our customers and our infrastructure. If we were to experience a shutdown, disruption or attack, it would adversely impact our product shipments and net sales, as order processing and product distribution are heavily dependent on our management information systems. Such an interruption could also result in a loss of our intellectual property or the release of sensitive competitive information or partner, customer or employee personal data. Any loss of such information could harm our competitive position, result in a loss of customer confidence, and cause us to incur significant costs to remedy the damages caused by the disruptions or security breaches. In addition, changing laws and regulations governing our responsibility to safeguard private data could result in a significant increase in operating or capital expenditures needed to comply with these new laws or regulations. Accordingly, our operating results in such periods would be adversely impacted. From time to time, we have experienced attempts to breach our security and attempts to introduce malicious software into our information technology systems; however, such attacks have not previously resulted in any material damage to us.

We are continually working to maintain reliable systems to control costs and improve our ability to deliver our products in our markets worldwide. Our efforts include, but are not limited to the following: firewalls, antivirus protection, patches, log monitors, routine backups with offsite retention of storage media, system audits, data partitioning and routine password modifications. Our internal information technology systems environment continues to evolve and our business policies and internal security controls may not keep pace as new threats emerge. No assurance can be given that our efforts to continue to enhance our systems will be successful. Although we maintain insurance, there can be no assurance that such insurance or the contractual limitations used by us to limit our liability will be sufficient to cover or limit any claims which may occur.

We are Subject to Risks Associated with Our Website. We devote significant resources to maintaining our website, ni.com, as a key marketing, sales and support tool and expect to continue to do so in the future. Failure to properly maintain our website may interrupt our normal operations, including our ability to provide quotes, process orders, ship products, provide services and support to our customers, bill and track our customers, fulfill contractual obligations and otherwise run our business, which would have a material adverse effect on our results of operations. We host our website internally. Any failure to successfully maintain our website or any significant downtime or outages affecting our website could have a material adverse impact on our operating results.

Our Products are Complex and May Contain Bugs, Vulnerabilities, Errors, or Design Flaws. As has occurred in the past and as may be expected to occur in the future, our hardware products, software products and third-party components or operating systems on which our products are based may contain bugs, vulnerabilities, errors or design flaws. Our products operate in conjunction with third-party products and components across a broad ecosystem. As has occurred in the past and as may be expected to occur in the future, our products, or products or components in conjunction with which they operate, may contain design flaws. These bugs, vulnerabilities, errors or design flaws, or fixes to these issues, may have a negative impact on the performance of our products, which could result in additional costs, liability claims, reduced revenue, or harm to our reputation or competitive position, any of which could have a material adverse impact on our operating results. Although we maintain insurance, there can be no assurance that such insurance or the contractual limitations used by us to limit our liability will be sufficient to cover or limit any claims which may occur.

We Are Subject to the Risk of Product Liability Claims. Our products are designed to provide information upon which users may rely. Our products are also used in “real time” applications requiring extremely rapid and continuous processing and constant feedback. Such applications give rise to the risk that a failure or interruption of the system or application could result in economic damage, bodily harm or property damage. We attempt to assure the quality and accuracy of the processes contained in our products, and to limit our product liability exposure through contractual limitations on liability, limited warranties, express disclaimers and warnings as well as disclaimers contained in our “shrink wrap” and electronically displayed license agreements with end-users. If our products contain errors that produce incorrect results on which users rely or cause failure or interruption of systems or processes, customer acceptance of our products could be adversely affected. Further, we could be subject to liability claims that could have a material adverse effect on our operating results or financial position. Although we maintain insurance, there can be no assurance that such insurance or the contractual limitations used by us to limit our liability will be sufficient to cover or limit any claims which may occur.

Compliance ~~With~~with Sections 302 and 404 of the Sarbanes-Oxley Act of 2002 is Costly and Challenging. As required by Section 302 of the Sarbanes-Oxley Act of 2002, this Form 10-Q contains our management’s certification of adequate disclosure controls and procedures as of ~~March 31,~~September 30, 2019. Our most recent annual report on Form 10-K also contains a report by our management on our internal control over financial reporting including an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2018 and an attestation and report by our external auditors with respect to the effectiveness of our internal control over financial reporting under Section 404. While these assessments and reports did not reveal any material weaknesses in our internal control over financial reporting, compliance with Sections 302 and 404 is required for each future fiscal year end. We expect that the ongoing compliance with Sections 302 and 404 will continue to be both very costly and very challenging and there can be no assurance that material weaknesses will not be identified in future periods. Any adverse results from such ongoing compliance efforts could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock price.

Our Business Depends on Our Proprietary Rights and We Have Been Subject to Intellectual Property Litigation. Our success depends on our ability to obtain and maintain patents and other proprietary rights relative to the technologies used in our principal products. Despite our efforts to protect our proprietary rights, unauthorized parties may have in the past infringed or violated certain of our intellectual property rights. We from time to time engage in litigation to protect our intellectual property rights. In monitoring and policing our intellectual property rights, we have been and may be required to spend significant resources. We from time to time may be notified that we are infringing certain patent or intellectual property rights of others. There can be no assurance that any future intellectual property dispute or litigation will not result in significant expense, liability, injunction against the sale of some of our products, and a diversion of management’s attention, any of which may have a material adverse effect on our operating results.

Our Business Depends on the Continued Service of Our Key Management and Technical Personnel. Our success depends upon the continued contributions of our key management, sales, marketing, research and development and operational personnel, including Alex Davern, our Chief Executive Officer, Eric Starkloff, our President and Chief Operating Officer, and other members of our senior management and key technical personnel. ~~Our key employees may voluntarily terminate their employment with us at any time.~~On October 29, 2019, we announced that Mr. Starkloff will become our President and Chief Executive Officer effective February 1, 2020. Mr. Starkloff will succeed Mr. Davern, who will continue to serve on our Board of Directors. The loss of the services of one or more of our key employees in the future could have a material adverse effect on our operating results. We also believe our future success will depend upon our ability to attract and retain additional highly skilled management, technical, marketing, research and development, and operational personnel with experience in managing large and rapidly changing companies, as well as training, motivating and supervising employees. The market for hiring and retaining certain technical personnel, including software engineers, has become more competitive and intense in recent years. Failure to attract and retain a sufficient number of qualified technical personnel, including software engineers, or retain our key personnel could have a material adverse effect on our operating results.

Our Operations are Subject to a Variety of Environmental Regulations and Costs that May Have a Material Adverse Effect on Our Business and Results of Operations. We must comply with many different governmental regulations related to the use, storage, discharge and disposal of toxic, volatile or otherwise hazardous chemicals used in our operations in the U.S., Hungary, and Malaysia. Although we believe that our activities conform to presently applicable environmental regulations, our failure to comply with present or future regulations could result in the imposition of fines, suspension of production or a cessation of operations. Any such environmental regulations could require us to acquire costly equipment or to incur other significant expenses to comply with such regulations. Any failure by us to control the use of or adequately restrict the discharge of hazardous substances could subject us to future liabilities.

Provisions in Our Charter Documents and Delaware Law May Delay or Prevent an Acquisition of Us. Our certificate of incorporation, ~~and~~ bylaws and Delaware law contain provisions that could make it more difficult for a third party to acquire us without the consent of our Board of Directors. These provisions include a classified Board of Directors, prohibition of stockholder action by written consent, prohibition of stockholders to call special meetings and the requirement that the holders of at least 80% of our shares approve any business combination not otherwise approved by two-thirds of our Board of Directors. Delaware law also imposes some restrictions on mergers and other business combinations between us and any holder of 15% or more of our outstanding common stock. In addition, our Board of Directors has the right to issue preferred stock without stockholder approval, which could be used to dilute the stock ownership of a potential hostile acquirer.

~~ITEM~~Item 2. ~~UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS~~Unregistered Sales of Equity Securities and Use of Proceeds

~~At March 31, 2019, there were 2,964,902 shares available for repurchase under our repurchase plan approved on April 21, 2010. This repurchase plan does not have an expiration date.~~ The following table provides information as of ~~March 31,~~September 30, 2019 with respect to the shares of our common stock that we repurchased during the ~~first~~third quarter of 2019.

Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of publicly announced plans or programs Maximum number of shares that may yet be purchased under the plans or programs

January 1, 2019 to January 31, 2019 183,317
$ 42.65
183,317
3,816,683

February 1, 2019 to February 28, 2019 851,781
45.30
851,781
2,964,902

March 1, 2019 to March 31, 2019 —
—
—
2,964,902
Total 1,035,098
$ 44.83
1,035,098
2,964,902



Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum number of shares that may yet be purchased under the plans or programs (1)

July 1, 2019 to July 31, 2019	—	—		—	1,850,402

August 1, 2019 to August 31, 2019	1,056,078	$	42.42	1,056,078	794,324

September 1, 2019 to September 30, 2019	—	—		—	794,324
Total	1,056,078	$	42.42	1,056,078	794,324
(1) On January 23, 2019, our Board of Directors amended our repurchase plan approved on April 21, 2010 to increase the aggregate number of shares of common stock that we are authorized to repurchase from 1,134,247 to 4,000,000. At September 30, 2019, there were 794,324 shares available for repurchase under such plan. This repurchase program does not have an expiration date.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

~~ITEM~~Item 5. ~~OTHER INFORMATION~~Other Information

None.



EXHIBITS
3.1(1)	Certificate of Incorporation, as amended, of ~~the Company.~~Registrant, effective May 14, 2013.
3.2(2)	Amended and Restated Bylaws of ~~the Company~~registrant
~~3.3(3)~~10.1 (3)	~~Certificate~~Agreement for Purchase and Sale of ~~Designation~~Real Property between the Company and Bridgepoint Parkway Investors, LLC, dated June 25, 2019, and the Reinstatement and First Amendment to Agreement for Purchase and Sale of ~~Rights, Preferences~~Real Property between the Company and ~~Privileges of Series A Participating Preferred Stock of the Company.~~
~~4.1(4)~~	~~Specimen of Common Stock certificate of the Company.~~
~~10.1(4)~~	~~Form of Indemnification Agreement.~~
~~10.2 (5)~~	1994 Employee Stock Purchase Plan, as amended.*Bridgepoint Parkway Investors, LLC, dated July 11, 2019.
~~10.3(6)~~31.1	National Instruments Corporation Annual Incentive Program, as amended.*
~~10.4(7)~~	2005 Incentive Plan.*
~~10.5(8)~~	2005 Form of Restricted Stock Unit Award Agreement (Non-Employee Director).*
~~10.6(9)~~	2005 Form of Restricted Stock Unit Award Agreement (Performance Vesting).*
~~10.7(10)~~	2005 Form of Restricted Stock Unit Award Agreement (Current Employee).*
~~10.8(11)~~	2005 Form of Restricted Stock Unit Award Agreement (Newly Hired Employee).*
~~10.9(12)~~	2010 Incentive Plan.*
~~10.10(13)~~	2010 Form of Restricted Stock Unit Award Agreement (Non-Employee Director).*
~~10.11(14)~~	2010 Form of Restricted Stock Unit Award Agreement (Performance Vesting).*
~~10.12(15)~~	2010 Form of Restricted Stock Unit Award Agreement (Current Employee).*
~~10.13(16)~~	2010 Form of Restricted Stock Unit Award Agreement (Newly Hired Employee).*
~~10.14(17)~~	2010 Form of Restricted Stock Unit Award Agreement (Performance Vesting).*
~~10.15(18)~~	RSU Vesting Acceleration Agreement between the Company and Alexander M. Davern, effective as of October 28, 2014.*
~~10.16(19)~~	~~Loan Agreement, dated as of May 9, 2013, by and among National Instruments Corporation, the guarantors from time to time party thereto and Wells Fargo Bank, National Association, as lender.~~
~~10.17(20)~~	2015 Equity Incentive Plan.*
~~10.18(21)~~	2015 Form of Restricted Stock Unit Award Agreement (Non-Employee Director).*
~~10.19(22)~~	2015 Form of Restricted Stock Unit Award Agreement (Performance Vesting).*
~~10.20 (23~~)	2015 Form of Restricted Stock Unit Award Agreement (Current Employee).*
~~10.21(24)~~	2015 Form of Restricted Stock Unit Award Agreement (Newly Hired Employee).*
~~10.22(25)~~	2015 Form of Restricted Stock Unit Award Agreement (Performance Vesting – Threshold Performance Goal).*
~~10.23(26)~~	2015 Form of Restricted Stock Unit Award Agreement (Employee-Time Based Vesting).*
~~10.24(27)~~	Performance Cash Incentive Plan.*
~~10.25(28)~~	~~First Amendment to Loan Agreement, dated as of October 29, 2015, by and among National Instruments Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as lender~~
~~10.26(29)~~	RSU Vesting Acceleration Agreement between the Company and Scott A. Rust, effective as of February 26, 2016.*
~~10.27(30)~~	~~Employment Agreement between the Company and Alexander M. Davern, dated August 29, 2016 and effective January 1, 2017.*†~~
~~10.28(31)~~	Offer Letter between the Company and Karen Rapp dated March 22, 2017.*
~~10.29(32)~~	~~Second Amendment to Loan Agreement, dated as of April 27, 2018, by and among National Instruments Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as lender.~~
~~10.30(33)~~	~~Offer Letter between the Company and Eric H. Starkloff dated October 23, 2018. *†~~
~~10.31(34)~~	Form of Restricted Stock Unit Award Agreement (Time Based and Performance Based).*
~~10.32~~	Form of Restricted Stock Unit Award Agreement (Non-Employee Director - One-Year Vesting).*
~~31.1~~	Certification of Chief Executive Officer, ~~Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant~~pursuant to Section 302 of the Sarbanes-Oxley Act of ~~2002.~~2002
31.2	Certification of Chief Financial Officer, ~~Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant~~pursuant to Section 302 of the Sarbanes-Oxley Act of ~~2002.~~2002



32.1	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to ~~18 U.S.C. Section 1350, as Adopted Pursuant to~~ Section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
(1)	Incorporated by reference ~~to the same-numbered exhibit filed with the Company’s~~from Registrant’s Report on Form 10-K for the fiscal year ended December 31, ~~2013.~~2013, filed with the Commission on February 20, 2014.
(2)	Incorporated by reference ~~to exhibit 3.1~~from Registrant’s Report on Form 8-K filed with the ~~Company’s Form 8-K~~Commission on January 28, ~~2019 (File No. 000-25426).~~2019.
(3)	Incorporated by reference tofrom Registrant’s Report on Form 10-Q for the ~~same-numbered exhibit~~fiscal quarter ended June 30, 2019, filed with the ~~Company’s Form 8-A on April 27, 2004 (File No. 000-25426).~~
~~(4)~~	~~Incorporated by reference to the Company’s Form S-1 (Reg. No. 33-88386) declared effective March 13, 1995.~~
~~(5)~~	~~Incorporated by reference to exhibit B of the Company’s Proxy Statement filed on March 30, 2017.~~
~~(6)~~	~~Incorporated by reference to the same-numbered exhibit filed with the Company’s Form 10-K for the fiscal year ended December 31, 2016.~~
~~(7)~~	~~Incorporated by reference to exhibit A of the Company’s Proxy Statement filed on April 4, 2005 (File No. 000-25426).~~
~~(8)~~	~~Incorporated by reference to exhibit 10.8 filed with the Company’s Form 10-Q~~Commission on August 2, ~~2006 (File No. 000-25426).~~2019.
~~(9)~~		~~Incorporated~~The exhibits required to be filed pursuant to the requirements of Item 601 of Regulation S-K are set forth in the Exhibit Index list noted above and are incorporated herein by ~~reference to exhibit 10.9 filed with the Company’s Form 10-Q on August 2, 2006 (File No. 000-25426).~~reference.
~~(10)~~		~~Incorporated by reference to exhibit 10.10 filed with the Company’s Form 10-Q on August 2, 2006 (File No. 000-25426).~~
~~(11)~~	~~Incorporated by reference to exhibit 10.11 filed with the Company’s Form 10-Q on August 2, 2006 (File No. 000-25426).~~
~~(12)~~	~~Incorporated by reference to exhibit 10.1 filed with the Company’s Form 8-K filed on May 17, 2010 (File No. 000-25426).~~
~~(13)~~	~~Incorporated by reference to exhibit 10.2 filed with the Company’s Form 8-K filed on June 24, 2010 (File No. 000-25426).~~
~~(14)~~	~~Incorporated by reference to exhibit 10.3 filed with the Company’s Form 8-K filed on June 24, 2010 (File No. 000-25426).~~
~~(15)~~	~~Incorporated by reference to exhibit 10.4 filed with the Company’s Form 8-K filed on June 24, 2010 (File No. 000-25426).~~
~~(16)~~	~~Incorporated by reference to exhibit 10.5 filed with the Company’s Form 8-K filed on June 24, 2010 (File No. 000-25426).~~
~~(17)~~	~~Incorporated by reference to exhibit 10.1 filed with the Company’s Form 8-K filed on April 25, 2014.~~
~~(18)~~	~~Incorporated by reference to exhibit 10.16 filed with the Company’s Form 10-K for the fiscal year ended December 31, 2014.~~
~~(19)~~	~~Incorporated by reference to exhibit 10.1 filed with the Company’s Form 8-K filed on May 13, 2013.~~
~~(20)~~	~~Incorporated by reference to exhibit B of the Company’s Proxy Statement filed on April 1, 2015.~~
~~(21)~~	~~Incorporated by reference to exhibit 10.18 filed with the Company’s Form 10-Q filed on July 31, 2015.~~
~~(22)~~	~~Incorporated by reference to exhibit 10.19 filed with the Company’s Form 10-Q filed on July 31, 2015.~~
~~(23)~~	~~Incorporated by reference to exhibit 10.20 filed with the Company’s Form 10-Q filed on July 31, 2015.~~
~~(24)~~	~~Incorporated by reference to exhibit 10.21 filed with the Company’s Form 10-Q filed on July 31, 2015.~~
~~(25)~~	~~Incorporated by reference to exhibit 10.22 filed with the Company’s Form 10-Q filed on July 31, 2015.~~
~~(26)~~	~~Incorporated by reference to exhibit 10.1 filed with the Company’s Form 8-K filed on December 16, 2016.~~
~~(27)~~	~~Incorporated by reference to exhibit C of the Company’s Proxy Statement filed on April 1, 2015.~~
~~(28)~~	~~Incorporated by reference to exhibit 10.1 filed with the Company’s Form 8-K filed on October 30, 2015.~~
~~(29)~~	~~Incorporated by reference to exhibit 10.26 filed with the Company’s Form 10-Q filed on May 2, 2016.~~*furnished herewith



~~(30)~~	~~Incorporated by reference to exhibit 10.27 filed with the Company’s Form 10-Q filed on October 31, 2016.~~
~~(31)~~	~~Incorporated by reference to exhibit 10.29 filed with the Company’s Form 10-Q filed on May 1, 2017.~~
~~(32)~~	~~Incorporated by reference to exhibit 10.30 filed with the Company's Form 10-Q on May 1, 2018.~~
~~(33)~~	~~Incorporated by reference to exhibit 10.30 filed with the Company's Form 10-Q on October 31, 2018.~~
~~(34)~~	~~Incorporated by reference to exhibit 10.1 filed with the Company's Form 8-K on January 28, 2019.~~
*	~~Management Contract or Compensatory Plan or Arrangement~~
†	~~Confidential treatment has been granted for portions of this exhibit. These portions have been omitted and submitted separately with the Securities and Exchange Commission.~~

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: ~~May 1,~~October 31, 2019

NATIONAL INSTRUMENTS CORPORATION

By: /s/ Karen Rapp

Karen Rapp

EVP, Chief Financial Officer

(Principal Financial Officer)

໿



	As of March 31, 2019
(In thousands)	(Unaudited)
			Gross		Gross
	Adjusted Cost		Unrealized Gain		Unrealized Loss			Fair Value
Corporate bonds	$	203,851	$	915	$	(347	)	$	204,419
U.S. treasuries and agencies	46,852		27		(1		)	46,878
Total Short-term investments	$	250,703	$	942	$	(348	)	$	251,297



	Three Months Ended March 31, 2018		Change in Constant Dollars			Impact of changes in foreign currency exchange rates on net sales			Three Months Ended March 31, 2019
(In millions)	GAAP Net Sales		Dollars		Percentage	Dollars		Percentage	GAAP Net Sales

Americas	$	119.7	3.2		2.7%	(0.3	)	(0.3)%	122.7
EMEIA	$	105.4	(3.4	)	(3.2)%	(3.2	)	(3.0)%	98.8
APAC	$	86.8	5.4		6.2%	(2.6	)	(3.0)%	89.6
Total net sales	$	311.9	5.3		1.7%	(6.1	)	(1.9)%	311.1